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Summary 
 Circulatory neutrophils exhibit an increased basal activation state in 
human pregnancy, which is overt in preeclampsia, a severe pregnancy 
specific disorder. Neutrophils play a defining role in combating infection either 
by phagocytosis or by degranulation; moreover, there have recently been 
shown to form neutrophil extracellular traps (NETs), containing extruded DNA, 
histones and granular proteins. The main activity of the NETs is the 
entrapment of bacteria, viruses and eukaryotic microorganisms, but more 
interestingly they seem to play a central role in the regulation of the overall 
inflammatory response. 
 Pregnancy presents an extraordinary immunological challenge to the 
maternal immune system. Successful gestation to term, birth and postpartum 
survival require tolerance to the semi-allogeneic fetus while maintaining the 
potential to mount a vigorous response against infection. During normal 
pregnancy insulin sensitivity also declines with advancing gestation, while a 
compensatory increase in insulin maintains the normal glucose homeostasis. 
Gestational diabetes mellitus (GDM) is a condition of glucose intolerance first 
recognized during pregnancy resulting in hyperglycemia of variable severity. 
GDM develops when the pancreatic beta cells are unable to regulate the 
increased insulin demand. During pregnancy there is increased degranulation 
and phagocytic activity of circulating neutrophils indicates that these immune 
cells play a key role in pregnancy adaptations. The mechanisms remain 
unknown, though sex hormones provide likely candidates. We therefore 
investigated and characterized the neutrophil activity during normal 
pregnancies and in pregnancies affected with gestational diabetes.  
 For this purpose, first we explored neutrophil activity during each 
trimester of normal pregnancy and in addition we studied the neutrophil 
response in pregnancies during and after the diagnosis of GDM. Neutrophils 
were isolated from EDTA blood, while products of NETosis were examined in 
serum and plasma. Cell-free circulating nucleosomes, myeloperoxidase 
(MPO), neutrophil elastase (NE), granulocyte-colony circulating factor (G-
CSF) and tumor necrosis factor α (TNFα) were determined by ELISA. NET 
formation was detected by Sytox Green, a fluorescent non-permeable DNA 
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dye and verified by immunofluorescence staining and morphometric analysis. 
The activated state of neutrophils was also evaluated by monitoring the 
reactive oxygen species generation. NET associated protein levels were 
analyzed by Western blots. 
 Our primary results during normal pregnancy show that neutrophil 
numbers in the periphery increase during gestation, in parallel with circulatory 
G-CSF. G-CSF induced NET formation and primed neutrophils toward an 
intense pro-NETotic response at concentrations prevalent in pregnancy. 
Moreover, detailed investigation of signaling related to the neutrophil 
activation revealed that the propensity to form NETs was advanced by both 
chorionic gonadotropin and estrogen/estriol. In contrast, progesterone acted 
by retaining cells in a primed pro-NETotic state, but inhibited their progress to 
formation of NETs. This coincided with the prevention of neutrophil elastase 
translocation from the cytoplasm to the nucleus, an indispensible step for NET 
release.  
 Neutrophils isolated from pregnant women with GDM were determined 
to be highly reactive and formed NETs more vigorously when compared to 
neutrophils isolated from healthy pregnant women, as observed by 
fluorimetry, immunocytochemistry and morphometric analysis. Moreover, high 
glucose and TNFα, which are increased in gestational diabetic individuals, 
primed neutrophils towards NET formation. The infiltration to the placenta of 
these primed neutrophils led to excessive NE release and the degradation of 
insulin receptor substrate 1 (IRS1).  
 Our data provide evidence that the increased neutrophil priming and 
NET formation observed during normal pregnancy is well modulated by the 
sex steroid hormones and G-CSF. Moreover we propose that neutrophils 
participate to the pathobiology of GDM. Our data demonstrate that the TNFα 
driven inflammation, resulting from high glucose levels in the circulation, 
enhances neutrophil priming and NET formation. The released NE can locally 
modify glucose tolerance and metabolism in the placenta, which probably 
results to the anatomical, physiological and functional changes observed in 
placenta of pregnant women suffering from GDM.  
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Chapter 1 
 Innate immune response 
 The immune function has been divided into innate and adaptive 
immunity. The innate immune cells are the first line of defense against 
invading pathogens. They are also required to initiate specific adaptive 
immune responses.  
 Innate immune responses are not specific to a particular pathogen in 
the way that adaptive immune responses are. They depend on specialized 
cells and soluble molecules that recognize conserved features of pathogens 
and are quickly activated irrespective of previous contact with the invading 
agents. The main effector cells of innate immunity are macrophages, 
neutrophils, dendritic cells (DC), natural killer cells (NK) and innate lymphoid 
cells (ILC).  
 
What triggers the innate immune response? 
 The recognition of damaged or dying cells either in the presence or 
absence of infection initiates the innate responses. After a pathogen invasion, 
molecules commonly found on the surface of microorganisms, or on the 
surface of the infected cells are called pathogen-associated molecular 
patterns (PAMPs). In contrast, damaged cells release damage-associated 
molecular patterns (DAMPs) as endogenous danger signals to alert the innate 
immune system. Cell damage or death in the absence of pathogen gives rise 
to DAMPs only, but when a pathogen attacks, both DAMPs and PAMPs will 
be present. The recognition of DAMPs and PAMPs activate the innate 
immune response by interaction with different receptors known as pattern 
recognition molecules (PRM), most of which are expressed by innate 
leukocytes and are called pattern recognition receptors (PRR). There is a 
limited repertoire of molecular patterns that can be recognized, however, each 
PRR recognizes a DAMP or PAMP that is shared by many different damaged 
cells or pathogens. Thus, PRRs give the innate immune response the 
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property of broad recognition. Furthermore, because the innate leukocytes 
expressing PRRs are present in large numbers, these cells do not need to 
multiply to work effectively and the response is immediate.  
 PRRs can be located in the plasma membrane of an innate leukocyte, 
or can be soluble molecules free in the leukocyte’s cytoplasm, or fixed in the 
membranes of the endosomes. The interaction between PRRs with a DAMP 
or PAMP stimulates the inflammatory response and the phagocytosis by cells 
such as neutrophils and macrophages. Many of the mammalian cell-surface 
pattern recognition receptors responsible for triggering host cell gene 
expression in response to pathogens are members of the Toll-like receptor 
(TLR) family. TLRs are abundant on the surface of macrophages and 
neutrophils and act as an alarm to the immune system whenever an infection 
occurs. 
 
General features of the innate immune response- Inflammation 
 The inflammatory response is characterized by pain, redness, heat and 
swelling at the site of infection. The local blood vessels dilate and become 
permeable to fluid and proteins, leading to local swelling and an accumulation 
of proteins, including the components of the complement cascade. 
Inflammation induces new gene transcription and synthesis of pro-
inflammatory cytokines. Especially activation of TLRs results in the production 
of lipid signaling molecules such as prostaglandins and peptide signaling 
molecules such as cytokines. Concurrently, the endothelial cells express cell 
adhesion proteins that facilitate the attachment of neutrophils, lymphocytes 
and monocytes. The activated macrophages produce chemokines that attract 
other cells, especially neutrophils and dendritic cells (DCs). Neutrophils are 
the first cells recruited in large numbers to the site of infection. The dendritic 
cells take antigens from the invading pathogens and carry them to the nearby 
lymph nodes.  
Once the threat is eliminated, the inflammation resolves naturally. However, if 
the inflammation fails to resolve and becomes chronic it can cause tissue 
damage and impair immune system function, as in sepsis and asthma.  
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Neutrophils 
Polymorphonuclear neutrophils (PMNs), also known as granulocytes, are 
the most abundant leukocytes in the human circulation with an important role 
in the early stages of inflammatory 
reaction. They constitute the 50-
70% of the human circulating 
leukocytes (Fig.1). Granulocytes 
are produced in the bone marrow 
as terminally differentiated cells 
and they have a half-life of 6 to 8 
hours [3] which can be extended 
after exposure to certain stimuli [4]. 
Neutrophils are sensitive to chemotactic agents, such as cleavage products of 
complement fractions (C3a and C5a) and substances released by mast cells 
and basophils. They are among the first cells to migrate from vessels to 
tissues attracted by chemokines, such as IL-8, and are activated by various 
stimuli, such as bacterial products, complement proteins (C5a), immune 
complex (IC), chemokines, cytokines. In response to different signals, 
neutrophils express a broad range of molecules that are crucial to the 
development of innate and adaptive immune responses against several 
pathogens	   [5]. Activated neutrophils, for example, release several cytokines 
that mediate the induction and recruitment of CD4+ Th1 cells, T helper 17 
(TH-17) cells and CD8+ T cells [6]. They can also act as antigen-presenting 
cells, as they can cross-present exogenous antigens to CD8+ T cells and 
provide co-stimulatory signals to activate T cells [7].  
 
Neutrophil morphology 
In the circulation mature neutrophils have an average diameter of 7-
10µm, their nucleus is segmented and their cytoplasm is enriched with 
granules [8]. Neutrophils contain four types of granules, which are formed 
consecutively during their maturation, and they are filled with pro-inflammatory 
Figure 1.:Neutrophil. Modified from 
Wikipedia. 	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proteins. The azurophilic or primary granules among other factors contain 
myeloperoxidase (MPO), neutrophil elastase (NE), cathepsin G, lysozyme 
and defensins. The specific or 
secondary granules contain mainly 
antimicrobial proteins such as 
lactoferrin and lysozyme. The 
gelatinase or tertiary granules store 
mainly metalloproteases such as 
gelatinase and a few antimicrobials. 
The secretory granules contain 
cytokines and important phagocytic 
receptors that are exposed to the 
neutrophil surface upon priming and fusion of these granules with the plasma 
membrane [9, 10]. The granules are classified according to their protein 
content and their differential ability to be exocytosed after neutrophil 
stimulation (Fig. 2). The azurophilic granules lack the soluble N-
ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) that 
would direct them to fuse with the plasma membrane [11]. This means that 
the contents of these granules are either deployed inside the phagosome or 
are released extracellularly via the formation of NETs. 
 
Neutrophil activation 
Neutrophil activation is usually a multistep process. It begins with the 
partial activation of cells as they transit through the vascular endothelium 
during the recruitment process (Fig. 3). After entry into the inflammatory tissue 
site, in response to pro-inflammatory stimuli in the tissue, neutrophils become 
fully activated, a state characterized by release of granule proteins, 
phagocytic activity, and the production of NETs. Neutrophils are relatively 
nonresponsive to a single stimulus, but exposure to one stimulus (e.g., 
lipopolysaccharide, tumor necrosis factor, chemokines, growth factors, 
adhesion) enhances the ability of the cell to mount an enhanced activation 
response to a second individual stimulus [12]. This effect, referred to as 
Neutrophil granulocyte 
H&E 
Granules (200-250) 
 
  primary (azurophilic) :  MPO, BPI, defensins, NE,  
     cathepsin G 
 
   secondary (specific) :  AP, lysozyme, NOX,  
     collagenase,  lactoferrin,  
     LL37 
 
   tertiary :  cathepsin, gelatinase 
Nucleus     multi-lobulated (2-5) 
Polymorphonuclear granulocyte – Neu, Bas, Eos 
 
the most abundant (40% to 75%) type of WBCs in mammals 
  
formed from stem cells in the bone marrow 
 
average lifespan of non-activated human Neu is 6-8h 
                   activated           is delayed. 
  
 
Figure 2.:Neutrophil serine proteases, 
adapted from[2]. 	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neutrophil priming, allows rapid and maximum neutrophil activation, including 
enhanced phagocytosis and radical oxygen generation [13].  
 
 
Figure 3.: Neutrophil functions. Modified from	  [14]. 
 
Neutrophil activation by PAMPs or DAMPs 
Neutrophils are able to recognize pathogens through cell surface and 
intracellular receptors that bind to microbe-specific molecules and host 
proteins, such as IgG and complement, that are opsonizing the microbe. 
These receptors induce intracellular signals that lead to full pathogen-killing 
capacity. 
The neutrophil pattern-recognition receptors (PRRs) recognize 
Pathogen associated molecular patterns (PAMPs), like lipopolysaccharide, 
peptidoglycan and lipoteichoic acids, double-stranded viral RNA and bacterial 
DNA. During sterile inflammation such as burns or hypoxia, necrotic cells 
release damage-associated molecular patterns (DAMPs), like high mobility 
group protein B1, mitochondrial formyl peptides, mitochondrial DNA, that are 
also recognizable by PRRs.  
In neutrophils, the primary endocytic PRRs are the C-type lectin 
receptors, the most important of which is Dectin-1 that recognizes fungal β-
glucan. Dectin-1, together with the integrin Mac-1, internalizes and eliminates 
fungal pathogens [15]. Another endocytic receptor is TREM-1 that binds 
various pathogens [16]. 
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The major type of PRRs on neutrophils is the TLRs, which recognize 
lipids, carbohydrates, peptides, DNA, and single- and double-stranded RNA 
[17]. At the RNA level, neutrophils express TLR-1, -2, -4, -5, -6, -8, and -10, 
and after GM-CSF treatment, TLR-9  [18]. TLR engagement primes 
neutrophils for enhanced responses to other stimuli, thus augmenting their 
phagocytic capacity, stimulating increased cytokine release and slowing 
neutrophil apoptosis [19].  
Other signaling PRRs include the cytosolic microbial sensors NOD1 
and NOD2, which recognize peptidoglycan-related molecules of gram-
negative and gram-positive bacteria respectively [20].  
Neutrophils express opsonic receptors and the engagement of the 
complement or the IgG-opsonized pathogens lead to a strong stimulation of 
neutrophil killing mechanisms. Resting neutrophils express two types of 
complement receptors, CR3 (also known as Mac-1) and CR4, which 
recognize targets opsonized by the complement activation product C3bi [21].  
Neutrophils express both low and high affinity receptors for the Fc 
portion of IgG, termed FcγRs. Resting human neutrophils express the low 
affinity activating FCγRIIA and FCγRIIB, which have low affinity for 
monomeric IgG, but high affinity for immune complexes, whereas activated 
neutrophils upregulate expression of the high-affinity FcγRI for IgG [22].  
A third major type of opsonin that engages both FcγRs and CRs are 
the pentaxin molecules. The best-studied pentraxins are the C-reactive 
protein (CRP) and serum amyloid P component (SAP), both of which are 
produced in the liver during inflammation. CRP and SAP can opsonize 
microbial pathogens through recognition of PAMPs. Association of CRP or 
SAP with a microbe induces rapid complement activation on the pathogen 
surface, facilitating recognition of the pathogen by neutrophil CRs. 
Additionally, both CRP and SAP are directly recognized by FcγRs to induce 
neutrophil activation [23].  
Neutrophils express a large repertoire of G protein-coupled receptors 
(GPCRs) that recognize bacterial products, like formyl peptides, as well as 
endogenous molecules released during inflammation, such as leukotrienes, 
chemokines (e.g., IL-8), C5a and adenosine. These GPCRs are involved 
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mainly in guiding neutrophil migration, but can promote neutrophil priming that 
in response to a second stimulus lead to full cellular activation [24].  
 
 
Neutrophil killing mechanisms 
Phagocytosis 
Neutrophils are efficient 
phagocytes that engulf and degrade 
microorganisms using a combination of 
oxidative and non-oxidative mechanisms. 
Once inside the neutrophils, 
microorganisms are sequestered in a 
specialized compartment called 
phagolysosome. During the oxidative arm, 
phagocytosis activates the membrane-
bound NADPH oxidase system and this 
generates large quantities of reactive 
oxygen species (ROS), such as 
superoxide (O2-), hydrochlorite (HOCl), 
hydrogen peroxide, hydroxyl redicals, and nitric oxide (NO) that are released 
into the phagolysosome (Fig. 4). The non-oxidative arm is constituted by 
fusion of neutrophil granules containing all the peptides and proteases with 
the phagolysosome leading to efficient killing of the microbes [2].  
 
Generation of reactive oxygen species 
Together with phagocytosis the respiratory burst is associated with the 
activation of NADPH oxidase. The assembly of a functional NADPH oxidase 
requires the inducible translocation of the cytosolic NADPH oxidase 
components p47phox, p67phox, and p40phox to the membrane, where the 
gp91phox (NOX2), gp22phox, and the GTPase Rac2 reside [25]. Its importance 
is revealed in patients with chronic granulomatous disease (CGD), who lack 
any one of the oxidase subunits. 
Figure 4. : Intracellular and 
extracellular bacterial killing. 
Adapted from [2] 
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The primary granule protein MPO catalyzes the formation of 
hypochlorous acid through reaction of hydrogen peroxide with chloride [26]. 
Nitric oxide production also complements ROS production by neutrophils. 
Nitric oxide (NO) is a short-lived (half-life of a few seconds), highly reactive 
molecule, which is produced by inducible nitric oxide synthase (iNOS). NOS is 
present in primary granules and is induced upon neutrophil priming (via TNF, 
IL-1, INF-γ) and during bacterial infection [27].  
 
Degranulation 
Degranulation involves the fusion of granules with the plasma 
membrane and the release of cytokines and antimicrobial contents into the 
extracellular space. All the types of granules have the capacity to degranulate 
extracellularly except from the primary granules. This is probably because 
they lack the soluble N-ethylmaleimide-sensitive factor attachment protein 
receptors (SNAREs) that would direct them to fuse with the plasma 
membrane [11]. The primary granules are largely degranulated into the 
phagosome thereby exposing ingested microorganisms to high concentrations 
of granule contents or are released extracellularly through the formation of 
neutrophil extracellular traps (NETs).  
 
NETosis 
Another antimicrobial strategy of neutrophils is the formation of NETs. 
NETs contain extruded DNA in the extracellular environment, decorated with 
histones and granular proteins. Their main activity is the entrapment of 
bacteria, viruses and eukaryotic microorganisms, but more interestingly they 
seem to play an important role in various autoinflammatory autoimmune 
diseases.  
 NETosis is activated not only by pathogens and their components, but 
also by activated platelets through many mechanisms such as TLR4 [28] or P-
selectin/PSGL-1 [29], the release of thromboxane A2 [30] and β-defensin-1 
[31]. In addition, both soluble and insoluble immune complexes (ICs) induce 
neutrophil extracellular trap release via FcγRIIIA and FcγRIIIB [32, 33].  
	   17 
 According to preliminary 
studies, anti-neutrophil antibodies 
that can directly induce NETosis 
NETosis have been isolated from 
patients suffering from the 
autoimmune disease Small Vessel 
Vasculitis (SVV) [34], Rheumatoid 
Arthritis (RA) [35] and Systemic 
Lupus Erythematosus (SLE) [36]. 
 At present, two NET formation 
mechanisms have been described 
(Fig. 5.), the NETs via a slow lytic cell death mechanism (120-240 min) and 
the rapid (5-60 min) release of NETs from live cells [1].  
 
Molecular mechanisms of NETosis 
 NET formation is a three-step process that begins with a change in the 
characteristic morphology of the nucleus. Accordingly, nuclear membranes 
disassemble and chromatin decondenses into the cytoplasm. Finally, the 
plasma membrane bursts and the NETs are released. The process is 
irreversible and is dependent on reactive oxygen species (ROS) such as 
superoxide, whish is generated by the NADPH oxidase Nox2. Several 
enzymes that regulate Nox2 activity such as protein kinase C (PKC) isoforms 
and MAPK kinases have been implicated in NET formation.  
 Interestingly, MPO appears to drive NETosis independently from its 
enzymatic activity in a mechanism that involves synergy with NE. In response 
to ROS, the neutrophil-specific protease, NE escapes from the azurophilic 
granules into the cytoplasm and translocates to the nucleus where it partially 
degrades histones. Subsequently, MPO associates with chromatin and 
promotes chromatin relaxation. MPO and NE synergize to drive massive 
chromatin decondensation [37] (Fig. 6).  
 
Figure 5. : Suicidal vs Vital NETosis. 
Adapted from [1] 
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Figure 6. :Chromatin decondensation by granule proteins. Modified from [37]. 
 
 Another prominent hallmark of NETosis that leads to chromatin the 
decondensation is the citrullination of the histone proteins by the 
peptidylarginine deiminase (PAD) enzymes. Citrullination, also known as 
deimination, is the conversion of positively charged arginine side chains into 
polar but uncharged citrulline side chains by deamination (Fig. 7). 
 
Figure 7. : Histone citrullination.Adapted from Mohanan S et al. . Hindawi 
Publishing Corporation Biochemistry Research International Volume 2012 
 
Especially the enzyme PAD4, the only of the five known peptidylarginine 
deiminases in human that has a classical nuclear localization signal, targets 
histone arginine and mono-methylarginine residues for citrullination in a 
calcium dependent reaction [38] [39]. Consequently, histones H3 and H4 and 
linker H1 histone lose their positive charge and their heterochromatin 
structure resulting in the disassembly of the histone-DNA complex [40].  
 
NETosis is a novel cell death mechanism 
 NETosis dinstinct from necrosis and apoptosis was first described 
following chemical stimulation with phorbol 12-myristate 13-acetate (PMA)	  
[41]. Neutrophil stimulation by PMA activates protein kinase C and the raf-
mitogen-activated protein kinase (MEK)-extracellular signal-regulated kinase 
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(ERK) pathway. In comparison to apoptotic cells, cells that undergo NETosis 
do not display eat-me signals to the phagocytes, such as phosphatidylserine 
(PS) before plasma membrane disruption. In contrast to apoptosis or 
programmed necrosis (necroptosis), during NETosis both the nuclear and 
granular membranes disintegrate, but plasma integrity is maintained. During 
this stage the antimicrobial granular proteins mix with the nuclear content. No 
morphologic signs of apoptosis are observed, such as membrane blebbing, 
nuclear chromatin condensation, PS exposure before plasma membrane 
rupture and internucleosomal DNA cleavage. Caspase activity is only 
detected during spontaneous apoptosis, but not during PMA-induced 
NETosis.  
 The presence of histones in NETs further indicates that nuclear and not 
mitochondrial chromatin is the major constituent of NETs. However, Simon’s 
group displayed that following priming with granulocyte/macrophage colony-
stimulating factor (GM-CSF) and subsequent short-term toll-like receptor 4 
(TLR4) or complement factor 5a (C5a) receptor stimulation, viable neutrophils 
are able to generate NETs. These forms of NETs contained only 
mitochondrial and not nuclear DNA and did not require neutrophil death [42].  
 
Antimicrobial activity of NETs 
 The main role of neutrophils is to eliminate microbes. It is probable that 
NETs evolved to restrain infection by trapping, preventing dissemination, 
inactivating virulence factors and eliminating microbes.  
 Trapping microbes prevents their dissemination from the initial infection 
site. Microbes most likely stick to NETs through charge interaction [43]. 
Nonetheless, pathogens to prevent binding to NETs, mask themselves with a 
capsule or change their surface charge [44]. Bacteria also attach nucleases to 
their surfaces to disengage themselves from NETs [45]. For example, group A 
S. pyogenes, pneumonococcus and Staphylococcus aureus encode 
endonucleases that detach them from NETs [46-48].  
 The antimicrobial activity of NETs depends on their structure, which 
provides a high local concentration of antimicrobials in direct proximity to 
trapped microorganisms. This structure is lost after DNase digestion. 
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Accordingly, the expression of DNases by the bacteria is essential for their 
pathogenicity [46].  
 NETs contain several proteins that kill or inhibit microbes. These 
include enzymes (lysozyme, proteases), antimicrobial peptides (BPI, 
defensins), ion chelators (calgranulin) and interestingly, histones. For 
instance, NE and other proteinases like Cathepsin G and Proteinase 3 (PR3) 
on the NETs specifically are able to cleave virulence factors [49].  
 
NETs in infection 
 NETs appear to be a form of innate immune response that kill a wide 
variety of microorganisms ranging from gram-positive to gram-negative 
bacteria, fungi, parasites and viruses [50, 51].  
 Several studies report that gram-negative bacteria such as S. flexneri 
and E.coli are able to trigger NET release and NET formation is important for 
the effectiveness against K. pneumonia [51]. Likewise, the gram-positive 
bacteria S. pneumoniae, S. pyogenes and S. aureus are good inducers of 
NETosis although many observations suggest that these bacteria may have 
evolved mechanisms to escape NETs [51]. Notable, although neutrophils and 
macrophages cooperate in order to confront M. tuberculosis, the bacteria are 
trapped but not killed [50]. These results suggest that NETs may be important 
to restrict physically these bacteria, preventing their spreading from the site of 
infection systemically.  
 NETs could also been induced by eukaryotic pathogens such as C. 
albicans and are sufficient to kill either the yeast or the hyphal form. A major 
antifungal component of NETs is calprotectin, a cytoplasmic protein, with 
calcium- and zinc-binding properties that when released bound to NETs leads 
to the killing of the fungus [43]. In addition to C. albicans, NETs have been 
described effective against A. nidulans and A. fumigatus [52]. 
 Little is known regarding the role of NETs in viral infections. Infection 
with an oncolytic poxvirus in a murine model resulted in an immune-
thrombotic response and generation of NETs. Presumably, NETs appeared to 
be useful for the clearance of the virus [53]. In contrast, viral infections appear 
to modulate host response in order to suppress NETosis. For instance, in 
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Feline leukemia virus (FeLV), neutrophil activation is inhibited through the 
inhibition of PKC and reduced ROS production [54]. On the other hand, 
secondary stimulation by Leishmania promastigotes induced NET formation 
[54]. In the case of HIV infection, although NETs are able to capture and 
neutralize the negatively charged HIV virions, engagement of DC-SIGN on 
dentritic cells (DCs) leads to the production of IL-10 by DCs, which 
suppresses NET formation [55].  
 The role of NETs has also been explored in parasitic infections. 
Leishmania parasites have been reported to trigger rapid NETosis in a 
manner dependent on NE and independent of ROS production [56]. NETs 
have also been detected in blood smears of pediatric patients infected with P. 
falciparum, one of the protozoa that cause Malaria [57]. During pregnancy 
malaria infection is associated with anemia and increased risk of spontaneous 
abortion, prematurity, low birth weight or stillbirth [50]. Another parasite that 
increases the risk for complications in pregnancy is the T.gondii [58].  
 
Neutrophils influence the resolution of inflammation 
 The inhibition of neutrophil influx is required to prevent the perpetuity of 
the inflammatory reaction, as these cells harbor the most destructive potency 
for tissue damage. Recent evidence suggests that neutrophils are involved in 
active induction of resolution of inflammation through dismantling chemokine 
and cytokine gradients [59], through pro-inflammatory lipid mediators that are 
switched to pro-resolving mediators [60] and by the inhibition of the activation 
and recruitment of the circulating neutrophils to the site of inflammation.  
 During the late, final phases of acute inflammatory responses, 
neutrophils switch their eicosanoid biosynthesis from leukotriene B4 (LTB4) to 
lipoxin A4 (LXA4), which can inhibit neutrophil recruitment through its 
interaction with its G protein coupled receptor LXA4R. Neutrophils can also 
contribute to the biosynthesis of resolvins (such as resolvin E1, resolvin E2, 
resolvin D1 and resolvin D2) and protectin D1, which are derived from omega-
3 essential polyunsaturated fatty acids. These pro-resolving lipid mediators 
inhibit neutrophil transendothelial migration and tissue infiltration [60].  
 The pro-resolving lipid mediators increase the expression of CC-
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chemokine receptor 5 (CCR5) by apoptotic neutrophils, and this, in turn, 
promotes the sequestration and clearance of CC-chemokine ligand 3 and 
CCL5 [59].  
 Other mechanisms are oriented to limit the pro-inflammatory effects of 
IL-1. Neutrophils stimulated with the anti-inflammatory cytokine IL-10 express 
IL-1 receptor antagonist (IL-1RA), a soluble molecule that binds to and blocks 
IL-1R1	   [61]. Moreover, the expression of type 2 IL-1 receptor (IL-1R2) binds 
IL-1 and prevents its interaction with the signal-transducing receptor IL-1R1	  
[62].  
 
The dark side of NETosis 
 Excessive NET formation is linked to tissue injury and is related to 
various neutrophil mediated pathologies. These include inflammatory 
diseases as Psoriasis [63] and Cystic fibrosis (CF) [51]. NETs are also a rich 
source of pro-inflammatory molecules and autoantigens and may be 
implicated in systemic autoimmune disorders as Systemic Lupus 
Erythematosus (SLE) [64], Small-vessel vasculites [34] and Rheumatoid 
Arthritis (RA)	  [65]. Excessive NET formation and endothelial cell activation are 
also associated with preeclampsia of pregnancy	  [66].  
 
NETs in inflammation 
 Psoriasis is a common inflammatory disorder of the skin and other 
organs. Psoriasis pathogenesis has been attributed to the externalization of 
IL-17 in the extracellular traps of neutrophils and mast cells [63]. 
 Cystic fibrosis (CF) is a debilitating hereditary disease, caused by a 
mutation in the CF transmembrane conductance regulator (CFTR) ion 
channel. When CFTR is not functional the viscosity of the sputum is very thick 
and is difficult to clear from the airways. The lack of sputum clearance 
promotes bacterial colonization leading to chronic airway inflammation and 
low life expectancy of the affected individuals [67]. Several studies have 
confirmed the abundance of NETs in CF sputum, where high levels of 
decondensed extracellular DNA, MPO and NE are detected [51, 68].  
	   23 
 Periodontitis is a chronic inflammation of the periodontium caused by 
bacteria in the gingival crevice. During this inflammatory condition, neutrophil 
influx leads to the formation of a purulent crevicular exudate that contains 
phagocytosing and Netting neutrophils [69].  
 Gout is characterized by acute joint inflammation triggered by 
inflammatory responses to uric acid crystals. Neutrophilia and neutrophil 
activation in gout is associated with the formation of proinflammatory NETs 
[70].  
 Preeclampsia is a severe inflammatory and vasculopathic condition 
that affects 1-2% of pregnant women and is characterized by proteinuria, 
oedema and hypertension. Untreated preeclampsia can develop into 
eclampsia accompanied by seizures, which can be life threatening for the 
mother and the fetus. Preeclampsia is associated with abundance of 
microdebris in the maternal blood circulation. Furthermore, massive numbers 
of NETs have been reported in the intervillus space of the affected placentae, 
apparently triggered by trophoblat microdebris and IL-8 [71]. This microdebris 
can activate neutrophils and stimulate the release of NETs in a dose-
dependent manner. Moreover, the increased IL-8 release by the placenta is 
able to recruit neutrophils and seem to be important for priming them to 
respond to the microdebris [72] [73]. 
 
NETs in autoimmune diseases 
 Systemic lupus erythematosus (SLE) is a diverse autoimmune disease, 
which mainly affects internal organs of the body as skin, heart, joints, lungs, 
liver, and kidneys. SLE patients exhibit elevated levels of antineutrophil 
cytoplasmic antibodies (ANCAs), antibodies against histones, DNA (ANAs) 
and ribonucleoproteins (RNP) that target host tissues [74]. NETs in lupus 
complexes contain LL37, which triggers TLR9 in plasmacytoid DCs, and 
subsequently secrete IFN-α. IFN-α has been shown to prime neutrophils to 
respond to autoimmune complexes by releasing NETs, which in turn activate 
pDCs further [75]. In a subset of SLE patients there is decreased NET 
degradation resulting in an imbalance between NET formation and NET 
clearance [76]. Moreover, low-density granulocytes isolated from the blood of 
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SLE patients tend to undergo spontaneous NET formation, while high density 
SLE neutrophils do not form NETs spontaneously [64]. 
 Small-vessel vasculitis (SVV) is a chronic autoinflammatory condition 
leading to necrotic inflammation of small-sized blood vessels and capillaries.  
Neutrophils play a central role in the pathophysiological process of SVV since 
they are responsible for endothelial damage and are the main target for 
antineutrophil cytoplasm autoantibodies (ANCAs) directed against granule 
proteins as MPO and PR3. These autoantigens are able to activate pDCs and 
B cells in a TLR-9 dependent manner, thus maintaining the autoimmune 
reaction and the production of NETs	   [34]. It has recently been described that 
the ANCA autoimmune response is facilitated as well, by insufficient T-cell 
and B-cell regulation and by the involution of an alternative complement 
pathway	  [77].  
 Rheumatoid arthritis (RA) is a systemic autoimmune diseaseassociated 
with chronic inflammation, primarily in the synovial joints. NETs are abundant 
in synovial fluids (SF), rheumatoid nodules, and skin of RA patients. In RA 
patients, NETs are decorated with citrullinated proteins that induce the 
generation of anti-citrullinated protein antibody (ACPA) autoantigens, which in 
turn, augment further NET release [35]. Interestingly, it seems that each 
different stimulus is able to determine the protein composition of the NETs 
[35]. RA patients show elevated levels of proinflammatory cytokines such as 
IL-17A and TNF-α that under LPS stimulation induce enhanced NET release. 
This NET release could be inhibited by blocking NADPH oxidase or PAD4, 
suggesting a possible NETosis mechanism [35, 78].  
 Type 1 diabetes (T1D) is an autoimmune disease resulting from the 
self-destruction of insulin-producing β-cells. Although reduced neutrophil 
counts have been observed in patients with T1D, the enzymatic activities of 
the neutrophil serine proteases NE and PR3 are increased and highly 
associated with the rise of NET formation. Notably, there is a positive 
correlation between the circulating levels of NE and PR3 and the titers of the 
autoantibodies against β-cell antigens. Moreover, the levels of the alpha1-
antitrypsin, the endogenous inhibitor of serine proteases, are decreased in 
these patients	  [79]. 
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NETs and thrombosis 
 Deep vein thrombosis (DVT) is caused by disturbances and stagnation 
in venous blood flow. Inflammatory conditions such as infection, pregnancy, 
obesity, trauma, cancer and autoimmune diseases are risk factors for the 
development of Deep vein thrombosis (DVT) [80, 81].  
 Experimental and clinical studies have shown high neutrophil counts 
and citrullinated histone H3 in venous thrombosis supporting that neutrophils 
and especially NETs contribute to thrombus formation. In addition, Fibrin and 
von Willebrand factor (vWF) have high affinity for histones hence they easily 
bind to NETs [81]. The interaction with the platelets seems also important, as 
the proteolytic ennzymes NE and cathepsin G activate platelet receptors 
resulting in the formation of aggregates on the NETs [82].  
 
NETs in cancer 
Neutrophils in cancer have been shown to have both protumor and 
antitumor activities	  [83].  
On the one hand, tumors produce various soluble factors such as IL8, 
CXCL5 and migration inhibitory factor (MIF), which activate and recruit 
neutrophils from the peripheral blood into the tumor tissue [84-86]. 
Neutrophils, on the other hand, release several mediators with protumor 
functions. For example, neutrophils release MMP9 and VEGF, which promote 
angiogenesis and tumor growth, MMPs, serine proteases, HGF and 
oncostatin promoting tumor migration and invasion and are also able to 
suppress the function of T cells by the expression of arginase 1	   [87, 88]. 
Furthermore, neutrophils enhance the metastatic potential of the tumor cells 
by facilitating their adhesion to sinusoids, via Mac-1/ICAM1 interaction [89]. 
G-CSF secreted by tumor cells predispose neutrophils to generate NETs, 
allowing distant cancer cells to metastasize and contributing to cancer 
associated thrombosis [90, 91].  
Neutrophil response, however, may prove to have antitumor effects. It 
is important that neutrophils are the most abundant population of circulating 
white blood cells that express FcγR and FcαR [83]. Neutrophils also recruit 
other effector cells of the innate and adaptive immune system and respond to 
	   26 
pathogen-derived biologics through the pattern recognition receptors. All the 
above make neutrophils very beneficial cytotoxic cells that promote the 
effectiveness of cancer immunothetrapy. Moreover, the conversion from 
protumor to antitumor neutrophil response has been achieved by 
pharmacologic immunomodulation, for example after the inhibition of TGF-b in 
the tumor host, the antitumor activity of neutrophils is enhanced [83].  
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Chapter 2 
Pregnancy 
Pregnancy is a unique condition, in which a genetically and 
immunologically semi-allogeneic fetus develops and survives to birth without 
rejection by the maternal immune system [92]. Fetal survival depends on 
profound changes in the mother’s host defense strategies. Tight immune 
regulation is essential, and involves maternal and fetal factors, which 
influence the immune system to allow the development and maintenance of 
immune tolerance and immune privilege [93, 94]. In this context, a variety of 
immune cells increase locally and modify their activities under the pregnancy 
specific hormonal milieu [95]. 
During pregnancy neutrophil numbers increase and alter their activities. 
Neutrophils exhibit an increased ability to migrate, their phagocytic activity is 
augmented and their oxidant release is greater compared to neutrophils from 
non-pregnant women [96, 97] In inflammatory pregnancy disorders such as 
preeclampsia, neutrophils exhibit a more pronounced activation state, which is 
accompanied by increased formation of NETs [71, 98].  
 
Initiation of Pregnancy 
 The first step towards pregnancy is fertilization. Fertilization is the 
merging of two specialized cells “the gametes” to form a new organism. At a 
cellular level, the fusion between the sperm and the egg requires a series of 
cell-matrix and cell-cell interactions [99]. The events of fertilization include a 
synaptic region, which is formed between the sperm and the egg via adhesion 
molecules, such as the IZUMO and the JUNO [100], the stabilization of the 
interaction and the recruitment of proteins that assist the fusion of the 
gametes [101], and the PLCζ that triggers calcium oscillations in the fertilized 
egg and initiates the downstream signaling pathways of egg activation and 
embryogenesis [102].  
 A few hours after the fertilization the dividing cell mass (morula) travels 
through the fallopian tube to the bottom part of the uterus. Seven days after 
the fertilization the embryo consists of about 100 cells that form a sphere filled 
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with fluid, called blastocyst. The implantation of the blastocyst to the 
endometrium of the uterus initiates pregnancy. The blastocyst is characterized 
by an inner cell mass, the embryoblast, which will subsequently form the 
embryo and a surrounding layer of trophoblast cells, which invade into the 
endometrium. The outer trophoblasts of the blastocyst differentiate into 
syncytiotrophoblasts and cytotrophoblasts [103]. These trophoblast cells 
compose the villi structures filled with maternal blood and form the umbilical 
cord. The placenta grows as an organ consisting of a fetal (decidua) part and 
a maternal part. Concurrently, the epiblast of the inner cell mass of the 
blastocyst differentiates into three primary germ layers, the ectoderm, the 
mesoderm and the endoderm from which the organs and tissues of the body 
develop during embryogenesis [103]. These fetal surrounding trophoblast 
cells play very important roles for a successful pregnancy. They provide a 
structural and biochemical barrier between the maternal and fetal 
compartments and also serve as an endocrine organ, which produces 
numerous growth factors and hormones that support and regulate the 
placental and fetal development and the maternal immune system [104].  
 
The immune system during pregnancy   
 The main role of the immune system during pregnancy is to protect the 
mother from infections. To achieve this the innate immune system is very 
efficient in cell migration in order to observe, to recognize and respond to 
invading microorganisms. As pregnancy proceeds, a massive influx of 
different subtypes of leukocytes occurs mediating various immune regulatory 
functions [105].  
Pregnancy has three distinct immunological phases that are 
characterized by distinct biological processes. The first stage, the 
implantation, the placentation and the early second trimester, resemble an 
open wound that requires a strong inflammatory response. During this first 
stage, the blastocyst in order to implant has to break through the epithelial 
lining of the uterus, has to damage the endometrial tissue to invade, and by 
the trophoblast replacement of the endometrium and vascular smooth muscle 
of the maternal blood vessels, to secure and adequate placental-fetal blood 
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supply [106]. All these activities create a variable battleground of invading 
cells, dying cells and repairing cells. An inflammatory environment is required 
to secure the adequate repair of the uterine epithelium and the removal of 
cellular debris. In addition, there are hormonal changes and other factors that 
characterize the first trimester of pregnancy as a proinflammatory phase. 
The second immunological phase of pregnancy is a period of rapid 
fetal growth and development. The mother, placenta and fetus are symbiotic 
and the predominant immunological feature is induction of an anti-
inflammatory state.  
Finally, during the last immunological phase of pregnancy, the fetus has 
completed its development and the mother experiences a renew inflammation 
probably to prepare to deliver the baby. Parturition is characterized by an 
influx of immune cells into the myometrium to promote revival of an 
inflammatory process. This pro-inflammatory environment promotes the 
contraction of the uterus, expulsion of the baby and rejection of the placenta. 
In conclusion, pregnancy is a pro-inflammatory and anti-inflammatory 
condition, depending upon the stage of gestation [107].  
 
NK cells  
 During the first trimester the most abundant leukocyte population in the 
decidua are the NK cells that constitute up to 70% [108]. They probable 
interact with the invading trophoblasts, which express a large repertoire of 
class I HLA-C and non-classical HLAC-G and HLA-E antigens and lack the 
expression of the classical HLA-A and –B antigens [109]. Their possible roles 
include the control of extravillous invasion, the control of uterine vascular 
remodeling and the local antiviral activity [110]. For a successful pregnancy, 
there is probably a balance between the killer and regulatory NK cells, since 
in normal pregnancy the NK cells mainly express TGF-β and IL-10, while in 
miscarriage they express INF-γ and kill extravillous trophoblasts [104].  
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Monocytes, macrophages and DCs  
 In humans the 20-25% of the decidual leukocytes are macrophages 
and their amount remains high until the onset of labor at term [111]. In the 
uterine decidual the macrophages can develop an inflammatory phenotype 
(M1 macrophages) that is characterized by elevated secretion of the 
inflammatory cytokines, such as IL-12 and TNF-a. Macrophages that 
differentiate in an environment that is dominated by Th2-biased cytokines, 
such as IL-4, IL-10, IL-13 or high glucocorticoid concentrations, develop an 
anti-inflammatory phenotype (M2 macrophages), which is characterized by 
arginase activity, scavenger receptor expression and secretion of IL-1 
receptor antagonist. In women with healthy, full-term pregnancies, there is 
increased M2 polarization of decidual macrophages as compared with women 
with preterm pregnancies [112]. 
 At the fetomaternal interface, monocytes contribute to spiral artery 
remodeling and fetal tolerance. They can differentiate into dendritic cells 
(DCs), which on the one hand, can promote immune tolerance by inducing 
effector T cell apoptosis and expansion of CD4+Treg cells and on the other 
hand can differentiate to mature APCs and prime effector T cells in draining 
lymph nodes [104].  
 
T cells and T regs  
 From the adaptive immune system, T lymphocytes constitute about 3-
10% of the decidual immune cells, suggesting that may not be crucial to 
trophoblast invasion [113].  
 Although during pregnancy there is an increased release of 
microparticles and exosomes by the growing placenta, the APCs can 
effectively capture them and then prime the fetal antigen-reactive T cells 
[114].  
 Immune tolerance during pregnancy can be explained by the 
expansion of the CD4+ CD25+ Tregs. CD4+ Treg cells can be generated in the 
thymus or induced peripherally from naïve CD4+ T cells and the expression of 
transcription factor forkhead box P3 (FoxP3) accounts for T cell functions in 
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suppressing autoimmunity or dampening inflammation at mucosal surfaces 
[115]. Interestingly, phylogenetic analyses identified a conserved noncoding 
DNA sequence 1 exclusively in the Foxp3 locus of placental mammals serving 
as a Foxp3 enhancer [116]. Many studies have indicated that the frequency of 
Treg cells increases during pregnancy in the decidua, which in turn 
suppresses effector T cell proliferation and immune responses against the 
embryo [117]. Moreover the hormones progesterone and 17beta-estradiol 
during the second trimester of human pregnancy have been shown to induce 
the systemic reduction of functionally suppressive CD4dimCD25highFoxp3+ 
Tregs [118]. 
 
CD8+ T cells and B cells 
As pregnancy proceeds there is also a proliferation of CD8+ Tcell, 
which coincides with the increased detection of fetal antigens systemically 
[119]. These CD8+ T regulatory or suppressor cells along with the estrogens 
may dampen antibody production by B cells contributing to fetal tolerance 
[120].  
 
Neutrophil granulocytes 
Neutrophils are a rich source of inflammatory mediators during 
delivery, such as plasminogen activators, eicosanoids, collagenase, elastase, 
and proinflammatory cytokines such as IL-1 and TNF [121]. Before labor, 
along with the cervical dilation, neutrophils accumulate in the cervical 
capillaries where they degranulate releasing collagen fibrils in the extracellular 
connective tissue matrix [122]. Furthermore, it has been suggested that 
MMPs derived from an influx of decidual neutrophils participate in the 
placental abruption and are associated with human preterm, premature 
rupture of the membranes [123]. In addition, it has been demonstrated that 
before the onset of labor neutrophils infiltration in the myometrium is low and 
rises during labor and that the neutrophil density is significantly greater in the 
lower than in the upper uterine segment [111].  
 Several chemokines participate in neutrophil recruitment into the 
reproductive tissues, including CXCL8, CXCL2 and CXCL3 [124] [125] [126].  
A diverse body of evidence currently serves to link overt or aberrant 
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PMN activation with the development of preeclampia (PE) [127]. These range 
from the original observations made by the Redman and Sargent group on 
excessive neutrophil activation in cases with PE [128], which was greater than 
in matching cases with sepsis, to our own observations on the presence of 
NETs in affected placentae [71]. In addition, deficient PP13 production may 
inadequately subvert neutrophil activity, thereby leading to inadequate 
modification of the maternal spiral arteries [129] [130].  
Of considerable interest is the translation of animal model data 
suggesting that the interplay between the complement system and neutrophils 
may play a key role in the development of both PE and recurrent fetal loss 
(RFL) [131] [132]. This has paved the way for the use of novel biologics 
targeting complement or TNFa activity as therapies [133] [131].  As such, the 
treatment of these disorders may finally enter the 21st century, making full 
use of cutting edge innovations [134] [135].  
The recent finding that antiphospholipid antibodies (aPL) can induce 
NETosis begs the question whether this mechanism is active in RFL or in 
lupus induced PE-like conditions [136]. This finding also suggests that PMN 
activation by aPL may involve both the complement system, as well as direct 
interaction by neutrophils with the aPL antibodies.  
In summary, the neutrophil is rapidly emerging as a key player in 
reproductive biology, on the one hand promoting implantation, spiral artery 
modification and even assisting with the process of parturition. On the other 
hand, aberrant or overt activation may play a key role in the development of 
complex pregnancy related disorders such as RFL or PE.  
 
Neutrophil transmigration to the placenta 
Neutrophil migration into tissues includes the following steps: tethering, 
rolling, adhesion, crawling and transmigration. It is initiated by the stimulation 
of the endothelium by other activated leukocytes or pattern recognition 
receptor (PRR)-mediated detection of pathogens. The activated endothelium 
expresses high levels of intracellular adhesion molecule-1 (ICAM-1), vascular 
cell adhesion molecule-1 (VCAM-1) as well as P- and E-selectins on its 
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surface [137] [138]. Neutrophil recruitment is mainly mediated through the 
linkage of P selectin glycoprotein ligand 1 (PSGL1), ESL1, CD44 and L-
selectin [139, 140]. The interactions of selectins with their glycosylated ligands 
mediate rolling and the expression of L-selectin is especially indicative of 
rolling neutrophils [141]. Neutrophil adhesion can be facilitated through 
activation by proinflammatory cytokines, chemoattractants or growth factors. 
Moreover, the stabilization of neutrophils to the endothelium is mediated by 
the interaction of chemokines with the endothelial cell heparan sulfates. 
Neutrophils express high levels of the integrins CD11a-CD18 (LFA1 / 
lymphocyte function associated antigen 1) and CD11b-CD18 (MAC1 / 
macrophage-1 antigen), which bind to endothelial cell surface molecules such 
as intracellular adhesion molecules 1 and 2 (ICAM1 and ICAM2) [142, 143]. 
The expression of CD11b-CD18 is important for the crawling of neutrophils 
[144]. Neutrophil transmigration requires integrins and cellular adhesion 
molecules (CAMS) such as ICAM1, ICAM2 and VCAM1, as well as platelet 
endothelial cell adhesion molecule 1 (PECAM1, also termed CD31), CD99, 
junctional adhesion molecules (JAMs), epithelial cell adhesion molecule 
(ECAM) and other endothelial cell mole- cules (Fig. 1) [145]. Transmigration 
occurs between (paracellu- larly) or through (trancellularly) endothelial cells 
and in order to pass across the membranes, neutrophils release specific 
proteases such as matrix metalloproei- nases (MMPs) and serine proteases. 
These enzymes are able to affect neutrophil migration by the degradation of 
elastin and collagen, thereby increasing the vascular permeability [146, 147]. 
Interestingly these proteins are under hormonal regulation during pregnancy 
[148]. On the other hand, neutrophils are able to recruit other neutrophils 
through the expression of interleukin-17 (IL-17), which induces the release of 
chemokines and cytokines such as interleukin-6 (IL- 6) and macrophage 
inflammatory protein – 2 (MIP- 2) by other cells that recruit neutrophils [149].  
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Figure 1. Sequential steps of neutrophil recruitment from the vasculature to the 
tissue. Two possible mechanisms of transmigration are described: (a.) paracellular - 
between endothelial cells; and (b.) transcellular - through endothelial cells. Major 
groups of adhesion molecules are marked. Rolling depends mostly on selectins, 
whereas adhesion, crawling and transmigration depend on integrin interactions. 
Chemokines lining the lumen of the vascular endothelium activate rolling neutrophils, 
thus inducing conformational changes of the integrins on the surface of the 
neutrophils and facilitating the subsequent events. Crawling neutrophils follow the 
chemokine gradient along the endothelium, which leads them to the preferential sites 
of transmigration. Figure adapted from [145]. 
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Immune modulation by pregnancy-associated hormones  	  
Concentrations of steroid hormones, including estrogens and 
progesterone (P4) are considerably higher during pregnancy than during other 
times in the female reproductive cycle and increase over the course of 
pregnancy, with highest levels achieved during the third trimester. Hormonal 
changes that occur during pregnancy underlie some of the distinct 
immunological changes associated with pregnancy.  
 
Estrogen 
Estrogens belong to the steroid hormones. Three major naturally 
occurring estrogens have been described in women namely estrone (E1), 
estradiol (E2) and estriol (E3). Within those E2 is the predominant estrogen 
produced during the 
reproductive years. The ovary 
produces high levels of E2, 
while smaller amounts are also 
produced by the adrenal cortex 
and from E2 precursors in fatty 
tissues [150]. In the normal 
menstrual cycle, E2 levels rise 
with follicular development, 
drop briefly at ovulation, and 
rise again during the luteal 
phase for a second peak. At the 
end of the luteal phase, E2 
levels drop to their menstrual levels unless there is pregnancy [151] (Fig. 2). 
During pregnancy, E2 levels increase continuously until term due to the 
production by the growing placenta [152]. 
Estrogen signaling is primary mediated through Estrogen Receptors 
(ERs). ERs not only are cytoplasmic but also appear within the nuclei of cells, 
Figure 2.: Hormones concentrations during 
pregnancy. 
Modified from Vitam Horm. 1977;35:109-47, 
Am J Obstet. Gynecol. 1796 Nov 15;126(6):678-
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regulaHon$is$essenHal,$and$involves$maternal$and$fetal$factors,$which$inﬂuence$the$immune$system$to$allow$the$development$and$
maintenance$of$immune$tolerance$and$immune$privilege$(4,$5).$$
!
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where ERs exist as inactive complexes with heat shock proteins and 
immunophilins. Each ER is a zinc finger-binding protein that, after activation, 
loses its cytoplasmic receptor-associated proteins and migrates as a TF to 
bind to the ERE (estrogen response element) of the DNA. Although both 
types of ERs transduce estrogen signals into a large variety of physiological 
responses in various organs, the biological events mediated by nuclear ERs 
occur slowly over hours or even days, whereas the intracellular signaling 
cascades triggered by cell-membrane ERs respond much faster, even within 
seconds. Estrogen receptors (ERs) are expressed in various lymphoid tissue 
cells as well as in lymphocytes, macrophages and dendritic cells. There are 
two subtypes of the receptor for estrogens, ERα and ERβ that exhibit 
differential expression in subsets of immune cells, with ERα being highly 
expressed in T cells and ERβ being upregulated in B cells [153]. The 
differential effects of estrogens on parameters of immune function may reflect 
not only the concentration of estrogen but also density, distribution and type of 
E receptors in immune cells. 
Estrogen can upregulate endothelial Nitric Oxide Synthase (eNOS) 
expression and can cause short-term coronary vasodilatory effects in humans 
by increasing NO production [154]. Especially in neutrophils, it has been 
shown that the neurons NOS (nNOS) protein expression is associated with 
the in vivo levels of circulating estrogen [155]. Estradiol along with P4 mediate 
delayed neutrophil apoptosis in both sexes and enhance female intracellular 
production of ROIs [156]. In addition, estadiol may act as a pro oxidant, 
promoting neutrophil degranulation such as MPO and NE release and 
oxidative stress by superoxide release [157]. Moreover, estrogens may 
regulate neutrophil activation indirectly as there have been defined estrogen 
response elements (EREs) in the PAD1, PAD3 and PAD4 gene promoters 
[158]. It was also shown that steroid hormones such as estrogen and 
progesterone are modulating the PAD activity [159] [160]. 
 
Estriol 
Estriol (E3) is produced in high concentrations by the fetoplacental unit 
during pregnancy and accounts for almost 90% of all estrogens produced 
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during pregnancy. Estriol is not present in non-pregnant females. The 
immunological effects of E3 have not been well characterized and it is 
assumed that the effects of E3 are broadly the same as E2 because both 
estrogens signal through the same ERs [161].  
 
Progesterone 
Progesterone (P4) is a steroid hormone primarily produced by the 
granulosa cells and the corpus luteum in the ovaries in non-pregnant females 
and during pregnancy by the placenta. Males produce progesterone in the 
adrenal glans and testes and this progesterone is the precursor of 
testosterone.  
In females P4 plays a critical role in reproduction and immune function 
at it plays a crucial role in mammary gland development [162], ovulation [163], 
embryo implantation and maintenance of pregnancy [164]. Pregnancy is 
associated with inhibition of Th1 signaling by peripheral T lymphocytes [165] 
and it has been shown that progesterone inhibits T cell, macrophage and NK 
cell activity [166]. Specifically, elevated levels of P4 stimulate the synthesis of 
progesterone-induced binding factor (PIBF) by lymphocytes [167]. In humans, 
PIBF increases over the course of pregnancy and drops significantly after 
birth, but in pathological pregnancies that result in preterm labor, abortion, or 
hypertension, concentrations of PIBF are low [168]. High concentrations of 
PIBF promote differentiation of CD4+ T cells into helper T cell type 2 (Th2) 
cells that secrete high concentrations of anti-inflammatory cytokines, including 
IL-4, IL-5, and IL-10 [169]. The Th2 bias that occurs during pregnancy 
corresponds with a reduction in inflammatory Th1 responses (e.g., production 
of INF-γ), both at the maternal-fetal interface and systemically in humans and 
animal models [170]. Successful pregnancies in humans are associated with 
elevated IL-4 and IL-10 and reduced IL-2 and INF-γ production by peripheral 
blood mononuclear cells (PBMCs), with differences in cytokine production 
being greatest during the third trimester of pregnancy [171]. Moreover in 
mouse models, it was noted that progesterone withdrawal recruits immune 
cells, such as neutrophils and macrophages into the cervix, and it is 
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suggested that this process might be contributing to the remodeling of the 
cervix before labor [172].  
The action of progesterone is mediated through cytosolic Progesterone 
Receptors (PRs) and also membrane-associated PRs (mPRs) [173]. They 
belong to the hormone receptor superfamily transcription factors, where ligand 
binding regulates gene expression thorough direct binding to promoter 
elements [174] or through interaction with other TFs [175]. Expression of PRs 
has been identified in epithelial cells as well as in mast cells, eosinophils, 
macrophages, DCs lymphocytes and neutrophils [176]. 
 
Human Chorionic Gonadotropin (hCG) 
Human chorionic gonadotropin (hCG) is a glycoprotein hormone that is 
produced by the syncytiotrophoblast cells of the placenta [177]. Its structure is 
homologous with the human luteinizing hormone (hLH). However the action of 
hLH in women is to act synergistically with FSH to induce ovulation and 
initiate the development of the corpus luteum, whereas the function of hCG is 
the stimulation of estrogen and progestins secretion by the corpus luteum, in 
the first few days after fertilization [178]. 
In women, migration of regulatory T cells to the pregnant uterus is 
mediated by the chemoattractant activity of hCG [179]. hCG has also been 
shown to promote the recruitment of regulatory T cells (Tregs) to the placenta, 
and thereby to play a key role in the induction of feto- maternal tolerance 
[180].  
 
G-CSF 
Granulocyte colony stimulating factor (G-CSF), also known as colony 
stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the survival, 
proliferation, differentiation and function of neutrophil precursors and mature 
neutrophils. G-CSF is a 18kDa, labile protein that act through specific 
membrane receptors, via JAK-STAT signaling pathways in an endocrine, 
paracrine or autocrine model [181].  
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Especially in reproduction, G-CSF and its receptor are localized in the 
granulosa cells, with concentrations being higher in the follicular fluid than in 
the serum [182]. G-CSF expression is also elevated during the menstrual 
cycle [183].  
During pregnancy, G-CSF has been detected in the human 
cytotrophoblast and syncytiotrophoblast on the placental side, and also on the 
maternal side, in the decidual stromal cells, endometrial glands and 
epithelium [184]. G-CSF might plays a major role in ovulation, as human 
ovarian surface epithelium secretes G-SCF [185] and serum concentration 
after ovarian hyperstimulation [182] is getting higher, as well as the follicular 
concentrations [183]. G-CSF might be implicated in local follicular 
inflammation [186] by attracting and activating leucocytes, leading to ovulation 
[187]. During embryogenesis, the role of G-CSF in immune tolerance in 
pregnancy can be attributed to the induction of IL-10 production [188]. 
Moreover, the local uterine production of G-CSF may contribute to the 
modulation of cytotoxicity of uterine NK cells, probably by suppressing the 
IFN-γ production [189].  
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Aim 
 
Since the particular effects of pregnancy on neutrophil physiology relating to 
formation of NET are unknown, our first aim was to explore neutrophil activity 
during normal pregnancy. For this purpose we used peripheral blood at 
discrete time-points during all three trimesters of pregnancy and we studied 
neutrophil priming towards the formation of NETs. Healthy non-pregnant 
female blood donors served as controls. In order to understand the factors 
that modulate neutrophil response during that condition we investigated the 
impact of prominent sex hormones expressed during gestation, specifically 
hCG, E2 and P4, and in parallel with G-CSF on neutrophil signaling towards 
NET formation.  
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Materials and Methods 
Human Subjects  
Pregnant women were recruited at the time of their routine examination 
at the end of the first (median gestational age: 12 weeks and 4 days - n=15; 
median age: 34.1 years) and second trimesters (median gestational age: 24 
weeks and 3 days - n=25; median age: 34.1 years) and at the time of elective 
caesarean section towards the end of the third trimester (median gestational 
age at delivery: 38 weeks and 4 days - n=35; median age: 34.1 years) (Table 
1). Healthy non-pregnant controls matched for age (n=45; median age: 33.5 
years), were recruited at the Blood Bank of the Swiss Red Cross, Basel 
(Table 1). Inclusion criteria for non-pregnant controls were fair general 
condition, female sex, age ≥ 25 and ≤ 45 years and for blood donors fulfilling 
national criteria for blood donation. Exclusion criteria were current or previous 
systemic autoimmune disease, asthma, reconvalescence after major illness, 
surgery, current medication with corticosteroids, immunosuppressive agents 
and malignant neoplasia or chemotherapy within 5 years before recruitment 
for the study. Exclusion criteria for pregnant subjects included any major 
complication of pregnancy or coincident disease, such as preeclampsia, pre- 
or post-term labor (<37 weeks or >42 weeks), intra-uterine growth retardation 
and viral, bacterial or parasitic infections. Informed, written consent was 
obtained from all subjects prior inclusion in the study, which was approved by 
the Ethical Review Board of Basel/Basel-Land, Switzerland. 
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Table 1. Demographic characteristics of the study cohort, i.e. women during 
the three trimesters of pregnancy and non-pregnant healthy controls. 
Table 1.  
 
 
Non-pregnant donors Pregnant donors P 
n 40  Total: 45 
IT:      15 
IIT:     25 
IIIT:    35 
na 
Maternal age (years) 32.7 (23-46) 33.9 (26-41) ns 
Gestational age (weeks) na IT:     12.5 (12-13) 
IIT:    24.7 (22-26) 
IIIT:   39.1 (37-41) 
na 
 
Values expressed as mean ± SE with minimum-maximum, where applicable; IT, first 
trimester; IIT, second trimester, IIIT, third trimester ns, not significant; na, not 
applicable. 
 
Blood cell count and preparation of plasma and serum  
Whole blood was collected into EDTA- and silicone-coated tubes 
(Sarstedt) and 25 µl of blood was analyzed by a Hemavet 950FS (Drew 
Scientific) for complete blood cell counts. Plasma and serum was collected 
and processed as described previously [190]. Samples were studied 
immediately or stored at -80°C until analyzed. 
 
Human neutrophil isolation  
Neutrophils were isolated by Dextran-Ficoll density centrifugation [65]. 
Cell viability was assessed by trypan blue dye exclusion in a haemocytometer 
and was routinely 96–98% with a purity of over 95%. Neutrophils were directly 
seeded in 24-well or 96-well plates and allowed to settle for 15 minutes at 
37°C under 5% CO2 prior to further experimentation. Time-points of 
measurements are given in the figure legends.  
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Cell free DNA isolation and quantification  
Cell free DNA was extracted from 850µl serum using the QIAamp 
Circulating Nucleic Acid Kit (Qiagen) and was quantified by TaqMan Real-time 
PCR (StepOneTM Plus Real-Time PCR System, Applied Biosystems) specific 
for the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene [190]. 
 
Stimulation and neutralization studies  
For in vitro incubation studies 2.5 x 104 neutrophils from healthy 
women were treated with 3% serum or 6% plasma derived from non-pregnant 
controls and pregnant donors during the first, second and third trimesters of 
gestation. All experiments were carried out over 3 hours in 4 to 6 replicates.  
Neutrophils from healthy controls were incubated with ascending 
concentrations of hCG, E2, E3, P4 or G-CSF, which covered the physiological 
plasma concentrations during gestation, individually or in different 
combinations.  
For the two-step stimulation in vitro experiments, neutrophils were 
pretreated with hormones or G-CSF as a primary stimulus for 60 min, and 
then exposed to the secondary stimulus (PMA or G-CSF) for another 120 min, 
for a total time of 3 hours. 
To neutralize sex hormones, pooled sera or plasma from the study 
groups of interest were pretreated for 30 minutes with fulvestrant (10 µg/ml, 
Sigma) and mifepristone (10 µg/ml, Sigma) for the neutralization of estrogens 
and progestins activity, respectively. To neutralize G-CSF, pooled sera or 
plasma from the study groups of interest were pretreated with anti-G-CSF 
antibody (0.2 µg/ml, Peprotech) for 30 minutes.  
 
Fluorimetric quantification and fluorescence microscopy  
NETs were quantified by SytoxGreen fluorimetry. 2.5x104 freshly 
isolated neutrophils were cultured in the presence of 0.2 µM SytoxGreen 
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(Invitrogen, Life Technologies) in a 96-well dark microtiter plate at 37°C under 
5% CO2 and left untreated or stimulated with the aforementioned agents over 
3 hours. PMA was used as the positive control. Fluorescence (excitation 485 
nm, emission 535 nm) was measured in a Biotek Synergy H1 Hybrid Reader 
(Biotek) and results given as DNA fluorescence (MFI). Photomicrographs in 
bright field and green fluorescence spectra were assessed with an Olympus 
IX50 inverted fluorescence microscope coupled to an Olympus XM10 
monochromatic CCD camera and analyzed with the Olympus CellSens 
Dimension software (Olympus). 
 
Neutrophil viability  
Apoptosis was detected by Annexin V/ 7-aminoactinomycin D (7-AAD) 
staining (BD BioSciences) according to the manufacturer’s instructions. 104 
cells were counted by flow cytometry using an BD Accuri™ C6 flow cytometer 
(Becton-Dickinson). The data were analyzed using Flowjo v10 software 
(Treestar).  
 
Cytokine proteome array  
Cytokines, chemokines and acute phase proteins were detected with 
the Human Cytokine Array Kit (R&D Systems) according to the 
manufacturer’s instructions. Pooled sera collected from control non-pregnant 
individuals and pregnant donors during the first, second and third trimesters of 
gestation were centrifuged and incubated with the pre-coated nitrocellulose 
membranes. After washing and addition of the detection antibody streptavidin-
HRP conjugates, the membranes were exposed to X-ray film (Fuji). The 
cytokine proteomic array comprised 36 targets spotted in duplicate on the 
membranes. The intensity of each spot in the captured images was analyzed 
with ImageJ analysis software (NIH Image Processing).  
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NE, MPO, cell-free histone/DNA complex, MPO/DNA complex and G-CSF 
protein analysis  
The concentrations of NE and MPO were measured in sera and 
plasma by sandwich ELISA, utilizing respectively the Elastase/a1-PI Complex 
ELISA Kit (Calbiochem) and the human MPO ELISA Kit. Histone/DNA 
complexes in sera and plasma were measured using the Human Cell Death 
Detection ELISAPLUS (Roche Diagnostics); nucleosomes in cell culture 
supernatants were detected similarly after incubation with DNase I (10U for 
5min) (Roche Diagnostics). To identify NET-associated MPO/DNA 
complexes, a modified capture ELISA was utilized [34]. NET associated MPO 
in culture supernatant was captured using the coated 96 well plate of the 
human MPO ELISA Kit, (Hycult Biotech), and the NET associated DNA 
backbone was detected using the anti-DNA-POD antibody of the Human Cell 
Death Detection ELISAPLUS (Roche Diagnostics). G-CSF serum and plasma 
protein concentrations were assessed with the Human G-CSF Quantikine 
ELISA Kit (R&D Systems). 
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Oxidative burst analysis  
NADPH oxidase mediated ROS production was measured either by a 
2′,7′-dichloro dihydrofluorescein diacetate (DCFH-DA) plate assay [191] or a 
luminol-based chemiluminescence microtitre plate assay [192] [193]. 
2.5  ×  104 neutrophils per well were incubated without or with stimulants 
mentioned above in dark 96-well microtitre plates with 25 µM DCFH-DA 
(Sigma-Aldrich), which reacts with ROS species produced in intracellular 
compartments (granules or phagosomes). Fluorescence was recorded 
immediately in a Biotek Synergy H1 Hybrid plate Reader (Biotek) and for 30 
minutes. The response was expressed as relative fluorescence units (RFU). 
Similarly, 2.5  ×  104 neutrophils per well were incubated without or with the 
aforementioned stimulants in white 96-well microtitre plates with 60µM luminol 
(5-amino-2,3-dihydro 1,4-phthalazinedione). Chemiluminescence was 
recorded every 5 minutes over a period of 30 minutes in a Biotek Synergy H1 
Hybrid plate Reader (Biotek), and the response was expressed as relative 
luminescence units (RLU). 
 
Immunohistochemistry, morphometric analysis and confocal 
microscopy  
1x105 neutrophils were seeded on poly-L-lysine-coated glass 
coverslips (BD Biosciences) in 24-well tissue-culture plates and allowed to 
settle prior to stimulation as described above. Coverslips were rinsed with ice-
cold HBSS and the cells fixed with 4% paraformaldehyde and blocked 
overnight (HBSS with 10% FBS, 0.1% Tween20, and 2mM EDTA) at 4°C. 
NETs were detected with rabbit anti-NE (Abcam), rabbit anti-MPO (Dako) and 
rabbit anti-citrullinated histone H3 (citH3, Abcam). Secondary antibodies were 
goat anti-rabbit IgG AF555, goat anti-rabbit IgG AF488 (Invitrogen Life 
Technologies), and goat anti-mouse IgG AF647. DNA was stained with 4′,6-
diamidino-2-phenylindole (DAPI, Sigma-Aldrich). NETs were visualized by 
using a Zeiss Axioplan 2 Imaging fluorescence microscope in conjunction with 
a Zeiss AxioCam MRm monochromatic CCD camera and analyzed with 
Axiovision 4.8.2 software (Carl Zeiss). A minimum of 20 fields (at least 1,000 
neutrophils) per case were evaluated for MPO/NE and DNA co-staining; 
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nuclear phenotypes and NETs were counted and expressed as percentage of 
the total number of cells in the fields. 
In another set-up, NETs were quantified by IHC staining of 2.5 x 104 
neutrophils per well in a 96-well plate with mouse anti-human MPO antibody 
(Abcam) and rabbit anti-human citH3 antibody (Abcam), or the respective 
isotype controls, followed by incubation with goat anti-mouse IgG AF555 and 
goat anti-rabbit IgG AF488 (Invitrogen Life Technologies). DNA was 
counterstained with 4′,6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich). 
NETs were visualized by using an Olympus IX81 motorized epifluorescence 
microscope (Olympus) in conjunction with an Olympus XM10 monochromatic 
CCD camera (Olympus) and analyzed with the Olympus CellSens Dimension 
software (Olympus). A minimum of 20 fields at 10× magnification (at least 500 
to 1,000 neutrophils) per sample were evaluated for MPO/citH3 and DNA co-
staining through ImageJ analysis software (NIH); nuclear phenotypes and 
NETs were determined, counted, and expressed as percentage of the total 
area of cells in the fields [194]. 
Images were captured on a Nikon A1R inverted microscope (Nikon) 
coupled to a Visitron CSU-W1 spinning disc confocal microscopy module 
(Visitron) and a Thor ablation laser (Thor Labs) using an UPL APO 60x/1.40 
oil objective lens with the Visiview Cell Analyser software (Visitron Systems, 
Version 3.1.2.2). 
 
Phagocytosis activity  
Neutrophil phagocytic activity was examined by uptake of latex beads 
coated with FITC-labeled rabbit IgG into cells (Cayman Chemical) according 
to the instruction manual. 1x105 untreated neutrophils exposed to various 
stimulants were resuspended in 200µl phagocytosis buffer to which FITC-
labeled beads (1:100) were added and incubated for 2 hrs at 37ºC. The 
amount of phagocytosis was determined by flow cytometry utilizing the 
BD Accuri™ C6 flow cytometer (Becton-Dickinson) and analyzed by Flowjo 
v10 software (Treestar). The uptake of the beads into neutrophils was 
additionally captured with an Olympus IX50 inverted fluorescence microscope 
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and phagocytosis quantified as described above with ImageJ analysis 
software. 
 
RNA isolation and quantitative real-time PCR  
Total RNA was isolated from 3x106 neutrophils by using the RNeasy 
Mini Kit (Qiagen). TaqMan real-time quantitative RT-PCR was performed 
utilizing the Applied Biosystems StepOne Plus cycler (Applied Biosystems) 
and TaqMan Gene Expression Assay primer and probe sets (Applied 
Biosystems) for ELANE (HS00236952_m1), MPO (HS00924296_m1), PAD4 
(HS00202612_m1), IL6 (HS00202612_m1), IL8 (HS00202612_m1), and TNF 
(HS00202612_m1). Data were normalized to the housekeeping gene B2M 
(HS99999907_m1), after a selection procedure from six different endogenous 
reference genes, as suggested in the MIQE guidelines [195]. Relative values 
were calculated with 2-DDCt analysis	  [196]. 
  
Protein isolation and western blot analysis for PAD4 and citrullinated 
histone H3 (citH3)  
Total protein was isolated by NucleoSpin TriPrep kit (Macherey-Nagel) 
from 5x106 neutrophils. All protein concentrations were determined with the 
MN Protein Quantification Assay (Macherey-Nagel). Western blotting was 
performed utilizing AnykD Mini-PROTEAN TGX Gels (Biorad) and 
nylon/nitrocellulose membranes (Biorad). Primary and secondary antibodies 
utilized were rabbit anti-MPO (Cell Signalling Technologies), rabbit anti-PAD4 
(Abcam), rabbit anti-citH3 (Abcam), mouse anti-β-Actin (Sigma), anti-rabbit 
HRP (Santa Cruz), anti-mouse HRP (Santa Cruz). HRP activity was detected 
by using SuperSignal West Pico Chemiluminescent Substrate (Thermo 
Scientific). Equal loading was verified using beta-actin. Western blots of 
citrullinated H3 (citH3) protein were prepared as described previously [197]. 
Gel documentation, densitometric analysis and protein quantification of the 
western blots was performed using the ChemiDoc XRS+ maging system 
(Biorad) with the ImageLab 4.1 image analysis software (Biorad). 
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Statistical analysis  
All data are presented as mean ± SE. Descriptive statistics for 
continuous parameters consisted of median and range, and categorical 
variables were expressed as percentages. Comparisons between patients 
and healthy controls were carried out by the Mann-Whitney U test with a 
Welch post-test correction. Statistical significance in multiple comparisons 
was by one-way analysis of variance (ANOVA) with a Dunn’s post-test 
correction. P values under < 0.05 were considered statistically significant. 
Data were processed in GraphPad Prism version 6.0 for MacOSX (GraphPad 
Software Inc., www.graphpad.com). Professional statistical assistance was 
provided by Andreas Schoetzau (www.eudox.ch). 
 
Results 
Neutrophil activity increases with progression of pregnancy  
We observed a substantial rise in neutrophil numbers during pregnancy 
(Fig. 1a). Using staining by SytoxGreen, a fluorescent cell-impermeable dye, 
we noted a marked increase in NET formation by neutrophils from pregnant 
donors versus baseline and non-pregnant controls, which at 3 hours was 
highly significant (Fig. 1b). This was reflected in increased MPO/cell free DNA 
complexes, which confirm the identity of the structures as NETs in culture 
supernatants (Fig. 1c). Since the morphology of the neutrophil nucleus 
evolves from a lobulated to a delobulated diffused and then to a decondensed 
NETotic phenotype prior to NET release [37], we measured the fraction of 
neutrophils with delobulated nuclei over time by morphometric analysis. As 
shown in Fig. 1d, upper panel and Fig. 1e, left panel, the baseline value of 
delobulated cells in the first trimester was significantly higher than in the non-
pregnant controls, with the neutrophil fraction generating NETs increasing 
further throughout pregnancy (Figure 1d, lower panel). 
Generation of ROS, a product of NADPH oxidase and crucial signalling 
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step for NET formation, rose significantly as pregnancy progressed 
(Supplementary Fig. 1a and 1b). Other key elements of signalling leading to 
NET formation were also increased in neutrophils from pregnant subjects: 
mRNA and protein levels of MPO, NE, and of PAD4 (Supplementary Fig. 1c, 
1d and 1e) as well as PAD4-mediated citrullination of H3 (Fig. 1e, right panel 
and Supplementary Fig. 1d, middle panel). In combination, these findings are 
highly suggestive of neutrophil priming towards NET formation.  
MPO and NE serum levels increased in a similar manner 
(Supplementary Fig. 1f), reflecting an elevated propensity for degranulation 
during pregnancy as reported previously	   [198]. The increase in NETs 
paralleled the increase in phagocytic activity (Supplementary Fig. 1g), also 
described previously [199]. Concomitantly, increases in IL-6 and IL-8 mRNA 
expression by neutrophils with the advancement of pregnancy were also 
observed (Supplementary Fig. 1h), providing further evidence of increasing 
overall activity of neutrophils during pregnancy. 
A primed, pro-NETotic state may also indicate an enhanced response to 
an additional stimulus	   [65]. We therefore assessed the effect of PMA on NET 
formation by neutrophils from pregnant women in vitro by 
immunofluorescence staining (Fig. 1g), SytoxGreen fluorimetry (Fig. 1f), 
morphometric analysis (Fig. 1h) and ROS production (Supplementary Fig. 1i 
and 1j). The results demonstrated that pregnancy-derived neutrophils 
generated NETs more vigorously following an additional stimulus compared to 
the controls. 
To summarize, peripheral blood neutrophils show a pro-NETotic 
phenotype that increases with advancing gestation. They are also 
progressively more responsive to a secondary stimulus in the course of 
pregnancy. Together with increased phagocytosis and degranulation, the 
adaptations of NET formation could amount to a more vigorous anti-microbial 
response in pregnancy. 	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Figure 1. NET formation and neutrophil pro-NETotic priming are augmented 
during pregnancy. (a) In vitro spontaneous NET formation by neutrophils from 
healthy controls pregnant donors in a 3 hour timecourse by fluorescent microscopy 
using dsDNA-binding fluorescent SytoxGreen dye. Magnification: 10x. Scale bars: 
100 µm. (b) In vitro spontaneous NET formation in a 3 hour timecourse by 
SytoxGreen quantification. (c) Quantification of NET-associated MPO/DNA complex 
levels in culture supernatants of neutrophils from healthy controls and pregnant 
donors at baseline (0h) and at 3 hours (3h). (d) Immunofluorescence staining for 
MPO (green) and DNA counterstain with DAPI (blue) at baseline (0h) and after 3 
hours of culture (3h). Magnification: 20x; Scale bars: 50 µm. (e) Morphometric 
analysis of the NETotic (MPO+) and proNETotic primed (citH3+) neutrophils from 
healthy donor controls, donors during pregnancy and post partum, at the baseline 
steady state (0h) and after a 3 hour culture (3h). (f) Fluorescent 
immunocytochemistry for MPO (green) and DNA counterstain with DAPI (blue) after 
a 2 hour culture after incubation with the NET-inducing agent phorbol-12-myristate-
13-acetate (PMA). Magnification: 20x; Scale bars: 50 µm. (g) In vitro spontaneous 
NET release monitored in a 3 hour time course by dsDNA-binding fluorescent 
SytoxGreen dye after application of PMA as secondary stimulus. Magnification: 10x. 
Scale bars: 100 µm. (h) Morphometric analysis of the NETotic (MPO+) and pro-
NETotic primed (citH3+) neutrophils from healthy donors and donors during 
pregnancy after application of PMA as secondary stimulus. Data are presented as 
mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (one way ANOVA 
followed by Bonferroni’s multiple comparison post-test). All experiments were 
performed at least 6 times with consistent results. IT, first trimester; IIT, second 
trimester; IIIT, third trimester; P, pregnancy; RFU, relative fluorescence units. 	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Supplementary figure 1. Signaling molecules involved in NET formation and 
neutrophil pro-NETotic priming are upregulated during pregnancy. Intracellular 
(a) and overall (b) oxidative burst in neutrophils from healthy control donors and 
donors during pregnancy by DCFH-DA and luminol detection, respectively. Western 
blot (c) and densitometric analysis (d) of PAD4, citH3, MPO and beta-actin protein 
expression levels in neutrophil lysates from healthy female controls and donors 
during pregnancy. (e) Phagocytic activity of neutrophils obtained from healthy female 
controls and donors during pregnancy. (f) NE, PAD4 and MPO gene expression 
analysis by Taqman qRT-PCR in RNA samples obtained from healthy female 
controls and donors during pregnancy. (g) Detection of serum NE and MPO levels by 
ELISA. (h) IL6 and IL8 gene expression analysis by Taqman qRT-PCR in RNA 
samples obtained from healthy female controls and donors during pregnancy. 
Intracellular (i) and overall (j) oxidative burst in neutrophils from healthy control 
donors and donors during pregnancy after treatment with PMA by DCFH-DA and 
luminol detection, respectively. Data are presented as mean ± SEM. *P < 0.05, **P < 
0.01, ***P < 0.001, ****P < 0.0001 (one way ANOVA followed by Bonferroni’s multiple 
comparison post-test). All experiments were performed at least 6 times with 
consistent results. IT, first trimester; IIT, second trimester; IIIT, third trimester; RFU, 
relative fluorescence units; RLU, relative luminescence units; AU, arbitrary units. 	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G-CSF effects on neutrophil priming and NET formation during 
pregnancy  
Pooled sera from pregnant women augmented NET formation by 
neutrophils from non-pregnant women in vitro (Fig. 2a and Fig. 2b). To identify 
the responsible factors, we performed a cytokine proteome array. There were 
considerable changes in cytokines and chemokines with a strong pro-
inflammatory signature in the pregnant as compared to the non-pregnant state 
(Supplementary Fig. 2a). Of the factors assessed, G-CSF showed a 
prominent signal increasing from the first through the third trimesters (Fig. 2c), 
which correlated with elevated numbers of neutrophils and lower numbers of 
monocytes and platelets (Supplementary Fig. 2b, 2c and 2d). Since G-CSF 
has been reported to elicit a pro-NETotic response in a mouse tumor model 
[91], we decided to study it in more detail.  
In vitro incubation of neutrophils from non-pregnant women with a range 
of concentrations of recombinant human G-CSF, including those present in 
normal pregnancy, increased the proportions of pro-NETotic priming and 
NETosis as detected by SytoxGreen fluorimetry (Fig. 2d, upper panel and Fig. 
2e), ROS production (Supplementary Fig. 3a and 3b), immunofluorescence 
microscopy (Figure 2d, lower panel) and morphometry (Fig. 2g). G-CSF at 
physiological pregrancy concentrations led to the highest pro-NETotic priming 
(citH3+ status), but low-level NET formation (Fig. 2g). G-CSF reduced 
phagocytic activity in favour of the increased pro-NETotic responses (Fig. 2h). 
Immunoblotting confirmed this finding, while real-time PCR demonstrated 
marked elevations of MPO, NE, PAD4 and citrullinated histone H3 (citH3) due 
to response to G-CSF treatment (Supplementary Fig. 3c, 3d and 3e). 
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Figure 2. G-CSF leads to neutrophil pro-NETotic priming during pregnancy. (a) 
In vitro spontaneous extracellular DNA release monitored in a 3 hour time course by 
dsDNA-binding fluorescent SytoxGreen dye microscopy after treatment of control 
neutrophils with pregnancy serum. Magnification: 10x. Scale bars: 100 µm. (b) 
Fluorimetric quantification of extracellular DNA release from neutrophils treated with 
pregnancy serum. (c) Detection of serum G-CSF levels by ELISA. (d) Evaluation of 
rhG-CSF activity by in vitro titration experiments using fluorescent SytoxGreen 
staining DNA and microscopy (upper panel) and immunofluorescence of peripheral 
neutrophils after incubation with rhG-CSF  at the indicated concentrations for MPO 
(red), citH3 (green) and DNA counterstain with DAPI (blue) after a 2 hour culture 
(lower panel), compared to untreated (UT) and PMA-treated neutrophils. 
Magnification: 10x. Scale bars: 100 µm. (e) Fluorimetric analysis of peripheral 
neutrophils after incubation with rhG-CSF at the indicated concentrations compared 
to untreated (UT) and PMA-treated neutrophils. (f) Morphometric analysis of the 
NETotic (MPO+/DNA+) and pro-NETotic primed (citH3 positive) neutrophils from 
healthy control donors under hormonal treatment. (g) Phagocytic activity of 
differentially rhG-CSF-treated neutrophils obtained from healthy controls, 30 minutes 
and 2 hours after stimulation. (h) NET formation in vitro monitored microscopically in 
a 3 hour time course with dsDNA-binding fluorescent SytoxGreen dye after a 1 hour 
pretreatment with physiological concentrations of rhG-CSF and application of the 
NET-inducing agents PMA as a second hit for additional 2 hours. Magnification: 10x. 
Scale bars: 100 µm. (i) Fluorimetry of extracellular DNA release of rhG-CSF-treated 
control neutrophils after addition of PMA. (j) Immunostaining for MPO (red), citH3 
(green) and DNA (blue) after a 3 hour in vitro co-culture of healthy neutrophils with 
rhG-CSF and addition of PMA. Magnification: 20x; Scale bars: 50 µm. (k) 
Morphometric analysis of the NETotic MPO positive and pro-NETotic primed citH3 
positive neutrophils from healthy non-pregnant donors under the aforementioned 
experimental setup. Data are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P 
< 0.001, ****P < 0.0001 (one or two way ANOVA followed by Bonferroni’s multiple 
comparison post-test). All experiments were performed at least 6 times with 
consistent results. IT, first trimester; IIT, second trimester; IIIT, third trimester; UT, 
untreated; RFU, relative fluorescence units. 
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Supplementary figure 2. Pregnancy changes in a broad series of pro- and anti-
inflammatory cytokines and chemokines and cell populations. (a) Detection of 
serum levels of a C5a, CD40L, CXCL1, G-CSF, CXCL11, CXCL12, CCL1, CCL5, 
cICAM1, IFNg, IL1Ra, IL13, IL17, IL23, MIF,and PAI1 by Human Cytokine Array 
analysis. Bar graphs depicting the differential counts of neutrophils (b), PBMCs (c) 
and platelets (d) in blood samples obtained from healthy female controls and donors 
during pregnancy. Data are presented as mean ± SEM. **P < 0.01, ***P < 0.001, 
****P < 0.0001 (one or two way ANOVA followed by Bonferroni’s multiple comparison 
post-test). 
 
In addition, we observed that treatment of normal neutrophils with 
concentrations of G-CSF detected in normal pregnancy (see above) rendered 
these cells highly responsive with NETosis to further stimulation with PMA as 
assessed by in vitro cell free DNA release (Fig. 2k and Fig 2l), ROS 
production (Supplementary Fig. 3f and 3g), immunofluorescence microscopy 
(Fig. 2m) and morphometry (Fig. 2n).  
To evaluate whether plasma G-CSF could drive the neutrophils to 
priming and to form NETs, endogenous G-CSF in plasma from pregnant 
women was sequestered by the use of an anti-G-CSF antibody. Neutralization 
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of G-CSF prevented sensitization of neutrophils to generate NETs (Fig. 3a 
and Fig. 3b) and reduced their capacity to generate ROS (Supplementary Fig. 
4a and 4b). Immunostaining revealed hypercitrullination of H3, consistent with 
a predisposition of neutrophils exposed to G-CSF to form NETs (Fig. 3c and 
Fig. 3d).  
These data suggest that G-CSF plays a vital role in promoting an 
enhanced pro-NETotic phenotype in pregnancy. 	  
	  
Figure 3. Pregnancy plasma G-CSF determines neutrophil pro-NETotic priming 
during gestation. (a) NET formation assessed microscopically in a 3 hour time 
course with SytoxGreen DNA binding dye after in vitro incubation of control 
neutrophils with pregnancy plasma with and without pretreatment with anti-G-CSF 
neutralizing antibody. Magnification: 10x. Scale bars: 100 µm. (b) Fluorimetric 
evaluation of extracellular DNA release in control neutrophils treated with pregnancy 
plasma in the presence of anti-G-CSF neutralizing antibody. (c,d) Fluorescent 
immunostainings for MPO (red), citH3 (green) and DNA (blue) (c) and morphometric 
analysis (d) of the NETotic MPO positive and pro-NETotic primed citH3 positive 
neutrophils from healthy non-pregnant donors under the aforementioned 
experimental setup. Magnification: 20x; Scale bars: 50 µm. Data are presented as 
mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (one way ANOVA 
followed by Bonferroni’s multiple comparison post-test). All experiments were 
performed at least 6 times with consistent results. RFU, relative fluorescence units; 
P, pregnancy plasma. 	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Supplementary figure 3. Plasma G-CSF determines neutrophil pro-NETotic 
priming during pregnancy. Intracellular (a) and overall (b) oxidative burst in 
neutrophils from healthy control donors treated with 2.5, 12.5 and 25 ng/ml 
recombinant human (rh)G-CSF by DCFH-DA and luminol detection, respectively. 
PMA was used as a positive control for NET formation related ROS generation. 
Western blot (c) and densitometric analysis (d) of PAD4, citH3, MPO and beta-actin 
protein expression in neutrophil lysates from healthy female controls treated with the 
aforementioned concentrations of rhG-CSF. (e) Phagocytic activity of neutrophils 
obtained from healthy female controls under the above described experimental 
conditions. (f) MPO, PAD4, NE, IL6, IL8 and TNF gene expression analysis by 
Taqman qRT-PCR in RNA samples obtained from healthy female controls treated in 
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vitro with the aforementioned concentrations of rhG-CSF. Intracellular (g) and overall 
(h) oxidative burst measured in PMA-treated control donors’ neutrophils 
preincubated for 1 hour with 12.5 ng/ml rhG-CSF by DCFH-DA and luminol 
detection, respectively. Data are presented as mean ± SEM. *P < 0.05, **P < 0.01, 
***P < 0.001, ****P < 0.0001 (one way ANOVA followed by Bonferroni’s multiple 
comparison post-test). All experiments were performed at least 6 times with 
consistent results. RFU, relative fluorescence units; RLU, relative luminescence 
units; AU, arbitrary units; UT, untreated. 
 
 
Supplementary figure 4. Neutralization of plasma G-CSF diminishes the release 
of NETs but not neutrophil priming towards NET formation. (a) Intracellular ROS 
generation from neutrophils co-cultured with 6% plasma derived from donors during 
the three trimesters of pregnancy and 50 ng/ml anti-GCSF neutralizing antibody 
monitored with DCFH-DA. Intracellular (b) and overall (c) oxidative burst in 
neutrophils from healthy control donors treated with 6% plasma derived from donors 
during pregnancy and 50 ng/ml anti-GCSF neutralizing antibody monitored by DCFH-
DA and luminol detection, respectively. PMA was used as a positive control for NET 
formation related ROS generation. Data are presented as mean ± SEM. *P < 0.05, 
**P < 0.01, ***P < 0.001, ****P < 0.0001 (one or two way ANOVA followed by 
Bonferroni’s multiple comparison post-test). All experiments were performed at least 
3 times with consistent results. RFU, relative fluorescence units; RLU, relative 
luminescence units; IT, first trimester; IIT, second trimester; IIIT, third trimester. 
 
 
Regulation of NET formation by the gestational hormonal milieu  
Pregnancy involves profound changes in the production of gestational 
hormones, namely hCG, E2, E3 and P4. In neutrophils from non-pregnant 
controls, incubation with these four sex hormones indicated that hCG and E2 
or E3 lead to increased NET formation, a feature not observed in P4 treated 
cells, or those treated with a combination of E2 and P4. On the other hand, 
phagocytic activity was greatest in P4 treated cells, (Fig. 4a-e). This facet was 
reflected in the measurement of ROS production, which was greatest in E2 
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treated cells and lowest for P4 treated cells, with the combination E2 and P4 
at the level of P4 alone (Supplementary Fig. 5a and 5b). hCG, E2 and P4 
influenced the levels of molecules required for NETosis in parallel with their 
effects on NET induction (Supplementary Fig. 5c, 5d and 5e). These were 
comparable to those of the neutrophils from pregnant women described 
above.  
The effects of the hormones on neutrophils from non-pregnant donors 
were also studied in various concentrations and combinations of hCG, E2, E3 
and P4 using the physiologic levels in pregnancy as a guide. The results 
obtained were assigned to categories for display in infograms. hCG, E2 and 
E3 induced vigorous NET formation as determined by SytoxGreen dye 
staining, while that induced by P4 was distinctly lower (Fig. 4f, first row and 
Supplementary Fig. 6a). E2 and E3 synergized with each other, while either 
combined with P4 showed less NET induction than when used alone. The 
combination of E2 and E3 with P4 led to lower levels of NET formation than 
with either estrogens alone (Fig. 4f and Supplementary Fig. 6a).  
Similar patterns were seen when NETs were determined 
morphometrically by DNA-bound MPO (Fig. 4g, left panel and Supplementary 
Fig. 6b) and by citH3+ nuclei (Fig. 4g, right panel and Supplementary Fig. 6c) 
indicated that neutrophils were primed for NETosis. High concentrations of 
hCG, E2 and E3 led to high cell free DNA release in vitro, while physiological 
concentrations resulted in a milder effect. (Fig. 4e and Supplementary Fig. 
6a). In all cases, P4 reduced NET release significantly, at physiologic 
concentrations as well as when co-incubated with E2 and E3 (Fig. 4e, 
Supplementary Fig. 5a to 5c and Supplementary Fig. 6a to 6c). Surprisingly, 
extensive citH3 immunostaining was also evident in P4 treated cells indicating 
priming for NETosis, but inability to progress to NETosis (Fig. 4g, right panel). 
Cells treated with either hCG or E2 displayed an enhanced pro-
NETotic response upon subsequent stimulation with PMA. While P4 reduced 
PMA induced NETs, this effect was less pronounced in cells treated with a 
combination of E2 and P4 upon secondary stimulation with PMA (Fig. 4h and 
4i). ROS production (Supplementary Fig. 6a and 6b) and immunofluorescence 
quantitation of MPO showed similar patterns, while terminal decondensation 
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of the nuclei was inhibited by combining E2 with P4 (Fig. 4j). At the same 
time, nuclear delobulation and hypercitrullination of H3 pointed to an 
enhanced primed state under the presence of P4 (Fig. 4j). 
To evaluate whether gestational hormone levels increase priming of 
peripheral blood neutrophils and formation of NETs, we pre-treated plasma 
isolated during gestation with the estrogen antagonist fulvestrant and the 
progestin agonist mifepristone in vitro. Fulvestrant was preferred to tamoxifen, 
because it does not induce NET formation [200]. Fulvestrant treatment of 
plasma from pregnant women partially prevented NET formation (Fig. 4k and 
4l). On the other hand, NET extrusion was distinctly increased after pre-
treatment of pregnancy plasma with the P4 receptor antagonist mifepristone 
(Fig. 4k, 4l and 4 m, left panel).	   Immunofluorescence of neutrophils exposed 
to mifepristone showed hypercitrullination of H3, consistent with a 
predisposition of neutrophils exposed to mifepristone-treated plasma to form 
NETs (Fig. 4m, right panel). 
Therefore, our data show that hCG, E2 and E3 stimulate NET 
formation and that PMA, as an additional stimulus, induces distinctly higher 
levels of NETosis than either of these agents alone. P4 does not induce 
formation of NETs, but rather diminishes the NETotic response to these 
agents either alone or in combination. 
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Figure 4. Neutrophil in vitro pro-NETotic priming is regulated by pregnancy 
hormones. (a) NET formation assessed microscopically in a 3 hour timecourse with 
SytoxGreen DNA binding dye after in vitro incubation of control neutrophils with 
physiological concentrations of the sex hormones hCG, E2 and P4. Magnification: 
10x. Scale bars: 100 µm. (b) Fluorimetric quantification of extracellular DNA release 
of gestational hormone treated control neutrophils. (c) Morphometric analysis of the 
NETotic (MPO+) and proNETotic primed (citH3 positive) neutrophils from healthy 
control donors under hormonal treatment. (d) Fluorescent immunocytochemistry of 
peripheral neutrophils after incubation with pregnancy hormones for MPO (red), citH3 
(green) and DNA counterstain with DAPI (blue) after a 2 hour culture. (e) Neutrophil 
phagocytic activity after a 2 hour incubation with pregnancy-specific hormones. (f) 
Information graphic summarizing in vitro spontaneous NET release monitored in a 3 
hour timecourse by dsDNA-binding fluorescent SytoxGreen dye after treatment with 
four ascending concentrations of each of the gestational hormones hCG, E2, E3 and 
P4, separately or in crossing combinations. (g) Information graphics summarizing in 
vitro spontaneous NET release and H3 hypercitrullination in a 3 hour timecourse 
after hormonal treatment as in (a), assessed by MPO (left panel) and citH3 (right 
panel) immunofluorescence microscopy and subsequent morphometric analysis, 
respectively. (h) In vitro spontaneous NET release monitored microscopically in a 3 
hour time course by fluorescent immunostaining for MPO (red), citH3 (green) and 
DNA (blue) after 1 hour pretreatment with physiologic concentrations of hCG, E2, P4 
and E2/P4 and stimulation with the NET-inducing agent PMA as a second hit for 
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additional 2 hours. Magnification: 20x; Scale bars: 50 µm. (i) Quantification of 
extracellular DNA release of gestational hormone treated control neutrophils after 
addition of PMA by fluorimetry. (j) Morphometric analysis of the NETotic MPO 
positive and pro-NETotic primed citH3 positive neutrophils from healthy non-pregnant 
donors under the aforementioned experimental setup. (k) Detection of in vitro 
spontaneous NET formation of neutrophils from healthy controls co-cultured with 
pregnancy plasma pretreated with mifepristone and fulvestrant in a 3 hour time 
course by fluorescent microscopy using dsDNA-binding fluorescent SytoxGreen dye. 
Magnification: 10x. Scale bars: 100 µm. (l) Fluorimetric quantification of extracellular 
DNA release of pregnancy plasma treated control neutrophils and preincubation with 
the sex hormone inhibitors mifepristone and fulvestrant. (m) Morphometric analysis 
of the NETotic (MPO+) and pro-NETotic primed (citH3 positive) neutrophils from 
healthy control donors after hormonal inhibition. Data are presented as mean ± SEM. 
*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (one or two way ANOVA followed 
by Bonferroni’s multiple comparison post-test). All experiments were performed at 
least 6 times with consistent results. RFU, relative fluorescence units; Pla, pregnancy 
plasma. 	  
	  
Supplementary figure 5. Sex hormones regulate neutrophil pro-NETotic 
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priming. Intracellular (a) and overall (b) oxidative burst in neutrophils from healthy 
control donors treated with physiologic pregnancy concentrations of hCG (50 IU/ml), 
E2 (50 ng/ml), P4 (50 ng/ml) and the 1:1 combination of E2 and P4 for 3 hours by 
DCFH-DA and luminol detection, respectively. Western blot (c) and densitometric 
analysis (d) of PAD4, citH3, MPO and beta-actin protein expression levels in lysates 
from healthy female control neutrophils treated with the aforementioned 
concentrations of gestational hormones. (e) Phagocytic activity of neutrophils 
obtained from healthy female controls during pregnancy. (f) PAD4, NE and MPO 
gene expression analysis by Taqman qRT-PCR in RNA samples obtained from 
healthy female controls during pregnancy. (g) IL6, IL8 and TNF gene expression 
analysis by Taqman qRT-PCR in RNA samples obtained from healthy female 
controls during pregnancy. Data are presented as mean ± SEM. *P < 0.05, **P < 
0.01, ***P < 0.001, ****P < 0.0001 (one way ANOVA followed by Bonferroni’s multiple 
comparison post-test). All experiments were performed at least 6 times with 
consistent results. RFU, relative fluorescence units; RLU, relative luminescence 
units; AU, arbitrary units; UT, untreated. 	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Supplementary figure 6. Sex hormones modulate neutrophil pro-NETotic 
priming and NET formation in vitro. (a) Fluorimetric quantification of extracellular 
DNA release of sex hormone-treated control neutrophils and in vitro culture for 3 
hours. (b) Morphometric analysis of the NETotic MPO positive and (c) pro-NETotic 
primed citH3 positive neutrophils from healthy non-pregnant donors under the 
aforementioned experimental setup. (d, e) Intracellular and (f) overall  oxidative burst 
in neutrophils from healthy controls treated with physiologic pregnancy 
concentrations of sex hormones for 1 hour and addition of PMA as a secondary hit 
for 2 hours (right panels) by DCFH-DA and luminol detection, respectively. Data are 
presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (one 
way ANOVA followed by Bonferroni’s multiple comparison post-test). All experiments 
were performed at least 3 times with consistent results. UT, untreated; RFU, relative 
fluorescence units; RLU, relative luminescence units; AU, arbitrary units. 
 
 
P4 suppresses NET formation while maintaining a stable primed 
neutrophil pro-NETotic state  
Since physiological concentrations of G-CSF fostered a pro-NETotic 
phenotype and gestational hormones modulate this process, we investigated 
whether pregnancy hormones influence NET formation when applied after G-
CSF treatment. SytoxGreen fluorimetric analysis revealed that hCG and E2 
augmented NET formation induced by pre-treatment with G-CSF (Fig. 5a and 
Fig. 5b). Strikingly, P4 promoted increased ROS generation by neutrophils 
(Supplementary Fig. 7a an Fig. 7b), yet retained a delobulated, primed state, 
retarding their progression to NET formation (Fig. 5a and Fig. 5b). 
Immunohistochemistry (Fig. 5c) and morphometry (Fig. 5d, left panel) were 
consistent with the cell-free DNA measurements of culture supernatants, 
while, as expected, low grade NETosis, yet high levels of primed citH3+ 
neutrophils were observed in the presence of P4 (Fig. 5d, right panel). Hence, 
P4 suppressed NET formation, maintaining a stable primed pro-NETotic state 
of neutrophils, and preventing or delaying active NET release despite 
advanced H3 citrullination. 
To investigate the possible mechanism, we resorted to 
immunofluorescent confocal microscopy, which showed that the nucleus of P4 
treated cells retained its lobulated state, despite high levels of H3 
citrullination. Furthermore, unlike in highly pro-NETotic G-CSF treated cells, 
there was no intermingling of NE with nuclear contents. It thus appears that 
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P4 hinders either the release or transfer of NE from the cytoplasmic granules 
to the nucleus, where it might assist in initiating the NETotic cascade (Fig. 
5e). 
 
	  
Figure 5. Sex hormones differentially modulate G-CSF-driven neutrophil pro-
NETotic priming. (a) In vitro NET formation assessed microscopically in a 3 hour 
timecourse with SytoxGreen DNA binding dye after without (upper panel) and with a 
1 hour pretreatment with 12.5 ng/ml rhG-CSF (lower panel) and stimulation with the 
gestational hormones hCG (50 IU/ml), E2 (50 ng/ml), P4 (50 ng/ml) and the 1:1 
combination of E2 and P4 for additional 2 hours. Magnification: 10x. Scale bars: 100 
µm. (b) Fluorimetric quantification of extracellular DNA release of rhG-CSF-treated 
control neutrophils after addition of pregnancy hormones at concentrations given 
under (a). (c) Fluorescent immunostaining for MPO (red), citH3 (green) and DNA 
(blue) after a 3 hour in vitro co-culture of control neutrophils with rhG-CSF and 
addition of hormones at concentrations given under (a). Magnification: 20x; Scale 
bars: 50 µm. (d) Morphometric analysis of the NETotic MPO positive and pro-
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NETotic primed citH3 positive neutrophils from healthy non-pregnant donors under 
the aforementioned experimental setup. (e) Fluorescent immunostaining and 
confocal microscopy for MPO (red), citH3 (green) and DNA (blue) after a 3 hour in 
vitro co-culture of control neutrophils with rhG-CSF and addition of P4. Magnification: 
63x; Scale bars: 10 µm. Data are presented as mean ± SEM. *P < 0.05, **P < 0.01, 
***P < 0.001, ****P < 0.0001 (one way ANOVA followed by Bonferroni’s multiple 
comparison post-test). All experiments were performed at least 3 times with 
consistent results. 
	  
Supplementary figure 7. Neutrophil in vitro pro-NETotic priming and NET 
formation is regulated by pregnancy hormones. (a) NET formation assessed 
microscopically at 3 hours with SytoxGreen DNA binding dye after in vitro incubation 
of control neutrophils with physiologic concentrations of the sex hormones hCG, E2, 
E3 and P4, and the combinations of E2, E3 and E2/E3 with P4. Magnification: 10x. 
Scale bars: 100 µm. 
 
 
Supplementary figure 8. G-CSF-driven neutrophil pro-NETotic priming is 
differentially modulated by sex hormones. Intracellular (a) and overall (b) 
oxidative burst in neutrophils from healthy control donors pre-treated for 1 hour with 
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12.5 ng/ml rhG-CSF and additionally co-cultured with physiologic pregnancy 
concentrations of hCG (50 IU/ml), E2 (50 ng/ml), P4, (50 ng/ml) and the 1:1 
combination of E2 and P4 for extra 2 hours by DCFH-DA and luminol detection, 
respectively. UT, untreated; RFU, relative fluorescence units; RLU, relative 
luminescence units. 
 	  	  
Discussion 
In the present study we demonstrate that neutrophils exhibit an activated 
pro-NETotic state and enhanced propensity to release NETs during normal 
pregnancy. This activity is modulated at several key levels. First, G-CSF 
seems to be a major signal inducing neutrophil release from the bone marrow 
throughout gestation, providing an important mechanism by which the number 
of circulating neutrophils and activation state is increased. Second, the degree 
of activation seems to be finely tuned by the unique stoichiometric balance of 
the sex steroid hormones, which are produced solely by the placenta and 
reach their peak concentrations towards term. Finally, P4 suppresses NET 
formation while maintaining a stable primed neutrophil pro-NETotic state (Fig. 
7). This is the first time such a regulatory mechanism of neutrophil activation 
is described in pregnancy, including the unique inhibitory role of P4 in NET 
formation.  
Our experiments revealed an unexpectedly large increase in the 
propensity of neutrophils to form NETs in normal pregnancy. This tendency 
increased with the advancement of gestation and concurred with activation of 
the major signaling steps leading to NETosis including ROS production, 
nuclear delobulation, translocation of cytoplasmic granule NE and MPO to the 
nucleus and the citrullination of H3. Expression of mRNA and protein of NE, 
MPO and PAD4 were also increased. These findings justify the addition of 
NET formation and the underlying signaling events to the previously described 
increased phagocytosis and degranulation as functional alterations of 
neutrophils in pregnancy [96]	  [201]	  [202].  
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Elevations of G-CSF in murine cancer models have been noted to 
promote neutrophilia and priming in conjunction with moderate NET formation, 
and to induce thrombosis under addition of low doses of LPS [91]. This raises 
the prospect that G-CSF could assume a similar role in neutrophil responses 
in pregnancy. Plasma from pregnant women increased priming and 
moderated NET formation, though specific neutralization of G-CSF abrogated 
NET formation, but not priming. Akin to G-CSF, hCG, E2 and E3 increased 
NET formation, yet did not promote pro-NETotic priming. The extensive 
analysis of various combinations of hCG, E2, E3 and P4 in promoting 
neutrophil priming demonstrated a crucial role of P4 as an antagonist of the 
pro-NETotic effects of hCG, E2 and E3. In contrast, G-CSF conditioned 
neutrophils treated with hCG, E2 and E3 showed enhanced NETosis. 
Furthermore, neutrophils exposed to P4 did not appear to readily progress to 
NETosis even though their nuclei were citH3+, indicating an arrest in the 
primed, pro-NETotic state. These findings mirror these observed in murine 
cancer models, as published for breast cancer [91]. Steroid sex hormones are 
involved in breast cancer, and neutrophils have been implicated in promoting 
or inhibiting breast cancer growth and metastasis depending on the 
expression of TGFβ and TNFα [203, 204]. Recent data from a different murine 
model of breast cancer support a fundamental role of neutrophils in fostering 
metastasis of the neoplasia to the lung	   [203]. Our data suggest that P4 or 
similarly acting agents could exert a beneficial inhibitory effect on neutrophil 
behaviour in the setting of mammary neoplasia. 
Since signalling up to the step of H3 citrullination, encompassing the 
activation and transfer of PAD4 from the cytoplasm to the nucleus, was 
unaffected by P4, we hypothesized it must utilize a different pathway. Given 
the essential role of translocation of NE from the cytoplasm to the nucleus for 
the extrusion of nuclear contents [37], we studied the influence of P4 on NE 
translocation. P4 completely prevented NE translocation to the nucleus in 
vitro, while the nucleus maintained its lobulation despite citrullination of H3. 
The specificity of P4 was confirmed by its inhibition with mifepristone, which 
abrogates the binding of P4 to its intracellular receptor	   [205]. These results 
concur with the opposing effects of estrogens and progestins on immune cell 
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function seen in other studies	  [206]	  [207]. 
The adaptation of neutrophils from peripheral blood could complement the 
alterations of Tregs and placental NK cells in balancing the reduced local 
neutrophil reactivity in the placenta by priming for a response to a second 
stimulus by infectious agents encountered in the systemic periphery. The 
potency of NET formation to mount effective responses against infectious 
agents has been shown in several studies [208], and increased preparedness 
to produce NETs could help ensure the protection of mother and fetus against 
infections during pregnancy. 
As with other states of increased immune system activity, inappropriate 
NET formation conceivably poses a threat to tissue integrity in pregnancy. In 
preeclampsia, for instance, increased NETosis coincides with inappropriate 
NET formation in the sinusoids of the trophoblast and the intervillous space. 
The interaction of excessive NETs with endothelial cells	  [71] or the trophoblast 
might provide the basis for the release of Flt-1 into the maternal circulation 
and the peripheral inflammatory activity, which underlies the elevated blood 
pressure and increased procoagulant activity, the hallmarks of PE	   [209]. 
Another relevant condition is the anti-phospholipid syndrome, in which anti-
cardiolipin antibodies interact with both neutrophils and the endothelium [93]	  
[210] [211].  
During pregnancy, the increased propensity to form NETs could at least 
partly explain the raised frequency of thrombosis [212]. In this case, it is 
possible that signaling elements along the PKC pathway substitute for NE 
signaling, as has recently been reported in a mouse model of deep vein 
thrombosis [213]. The effects of NET formation on the endothelium and on 
thrombosis related to pregnancy conditions find counterparts in tumor-
associated thrombosis, inflammatory blood vessel diseases and 
atherosclerosis	  [214]	  [215]	  [216] [91].  
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Figure 6. Progesterone antagonizes the estrogen and G-CSF driven neutrophil 
extracellular trap formation during pregnancy. Neutrophils during pregnancy lie 
under the increased influence of cytokines, e.g. G-CSF, and sex hormones. This 
specific milieu appears to poise the neutrophils in a stable pro-NETotic primed state. 
Depending on the stimulus, for instance microorganisms (MO), neutrophils react by 
phagocytosis or degranulation. When a different NETotic stimulus is present, such as 
excessive placentally derived plasma microparticles (MP) in preeclampsia, primed 
neutrophils react with overt NET release. Pro-NETotic combinations of hormones 
and cytokines are given in green, the most potent in bold green. Inhibitory 
combinations are given in red, the most potent in bold red. 
 
 
In summary, we show that E2 and E3 lead to pronounced neutrophil 
activation and NET release in vitro, which was reflected by increased NETosis 
during pregnancy (Fig. 6). Remarkably, treatment with P4 significantly 
reduced NETosis and antagonized the pro-NETotic effects of E2 and E3. 
Strikingly, P4 promoted a pro-NETotic citH3 positive primed state of 
neutrophils, akin to that induced in vitro by G-CSF in our experiments and 
previously reported in murine models of several cancers [91]. These 
observations are corroborated with a detailed analysis of signaling pathways 
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and extended by the finding that P4 inhibited the translocation of NE from the 
cytoplasm to the nucleus, which is required for the progression of NETosis. 
Our analysis of ex vivo and in vitro effects of sex steroids and G-CSF 
during gestation provide conclusive evidence that increased neutrophil pro-
NETotic priming and NET formation form a significant part of the adaptations 
of the immune system in pregnancy. Furthermore, our observations 
concerning P4 provide a basis for further analysis of the physiologic sex 
hormone influences on innate immunity and neutrophil functions in members 
of the female sex, as well as the implications and consequences of disturbed 
function on inappropriate inflammation and pathogenesis. Our findings 
regarding neutrophil responses during normal pregnancy provide new insight 
concerning gestational and hormone-driven pathologies, since neutrophil 
recruitment, activation and NET release could be associated with excessive 
endothelial and placental injury. 	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Chapter 3 
Gestational Diabetes Mellitus 
Gestational Diabetes Mellitus (GDM) is defined as glucose intolerance 
resulting in hyperglycaemia of variable severity with onset or first recognition 
during pregnancy	   [217]. Prevalence is most often reported as 2-6% of 
pregnancies in Europe	  [218]. 
In humans, the balance between adequate insulin secretion and insulin 
sensitivity maintains the normal glucose tolerance. The ability of insulin to 
dispose of carbohydrates is based on the pancreatic beta-cell response to 
glucose by secreting insulin and the sensitivity of the glucose utilizing tissues 
to insulin	   [219]. During normal pregnancy, insulin sensitivity declines with 
advancing gestation. In physiological conditions, a compensatory increase in 
insulin maintains the normal glucose homeostasis. GDM occurs when 
pancreatic beta cells are unable to face the increased insulin demand during 
pregnancy [220]. 
 
 Glucose regulation during normal pregnancy 
From the beginning of pregnancy fasting blood glucose moderates and 
proceeds with advancing gestation [221]. Insulin sensitivity declines during 
gestation to reach at late gestation (34-36 weeks) 50-60% of the non-
pregnant condition [222]. As a consequence to insulin resistance, fasting 
insulin concentrations increase. These changes in insulin sensitivity are 
inversely related to changes in the maternal body fat mass [223]. These 
alterations in the maternal metabolism have been attributed to placental 
factors, such as progesterone and estrogen	   [224]. In addition, changes in 
inflammatory factors such as TNFα might also be involved in the insulin 
resistance during pregnancy	   [225]. It has also been reported that the level of 
placental TNFα determines the insulin resistance in pregnancy independently 
from the fat mass changes	  [226].  
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Pathogenesis of GDM 
It is suggested that women who develop GDM are before pregnancy insulin 
resistant compared to women who did not develop GDM	  [227]. The significant 
decrease in insulin sensitivity in late gestation is correlated with the decreased 
insulin sensitivity that pre-exists prior to pregnancy	   [228]. The circulating 
factors TNFα and IL-6 have also been inversely correlated with insulin 
sensitivity and the pathogenesis of GDM	   [225]	   [229]. From the other factors 
that are elevated in GDM, leptin is mainly associated with the prior to 
pregnancy maternal weight	  [230].  
 
Maternal and fetal complications of GDM 
The most common maternal outcome of GDM in the clinic is Caesarean 
section. Furthermore, gestational diabetes raises the risk for preeclampsia, 
which combines gestational hypertension and proteinuria. Adverse fetal 
complications of GDM are mainly related to macrosomia caused by fetal 
hyperinsulinism in response to high glucose levels coming from maternal 
hyperglycemia. Moreover, the developing fetus has higher risk of experiencing 
respiratory distress syndrome, developing hypoglycemia or Type 2 diabetes 
later in life and having higher morbidity and mortality incidence. High-risk 
patients are screened as early as possible using fasting plasma glucose and if 
normal, they proceed with a 75g Oral Glucose Tolerance Test (OGTT) at 24-
28 weeks of gestation [231].  
 
Neutrophils in diabetes 
Traditionally neutrophils are not regarded as key factors in the aetiology of 
diabetes, however, recent data have suggested that they could contribute to 
the autoimmune condition underlying Type 1 Diabetes (T1D) [232] or the 
inflammatory condition occurring in Type 2 Diabetes (T2D)	   [14]	   [233]. 
Recently it was suggested that NETosis is reduced in T2D affected individuals 
and that this in part is mediated by elevated glucose levels	  [234]. Patients with 
diabetes mellitus (type 1 or type 2) exhibit impaired wound healing and it has 
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been recently described that this defect could stem from enhanced NETosis	  
[235]	  [236].  
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Aim 
  In an attempt to explore whether hyperglycemia affects neutrophils 
activation during pregnancy, we investigated the biological response of 
neutrophils in pregnant women with gestational diabetes. Moreover we 
explored the effect of primed neutrophils in the placenta. 
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Methods 
Human Subjects 
 Pregnant women (n=20) were recruited at the time of their routine 
examination for glucose intolerance at the 24th to 28th weeks of pregnancy 
and had no preexisting diseases such as diabetes mellitus or high blood 
pressure (median gestational age: 26 weeks and 2 days; median age: 33.7 
years). 12.5ml of blood was collected before, 60 and 120 minutes after the 
oral glucose tolerance test, at the 24th to 28th weeks of gestation and 48 
hours after delivery. At the time of caesarean section placenta tissue was also 
collected. Healthy non-pregnant controls matched for age (n=10) were 
recruited at the Blood Bank of the Swiss Red Cross, Basel.  
 Inclusion criteria for the pregnant subjects included healthy singleton 
pregnancies. Exclusion criteria included maternal diseases like hypertension, 
diabetes mellitus and chronic disease, known infection like hepatitis or human 
immunodeficiency virus, maternal history of hypertensive diseases in previous 
pregnancy, fetal genetic, chromosomal or intervention-requiring morphologic 
abnormalities. Informed, written consent was obtained from all subjects prior 
inclusion in the study, which was approved by the Ethical Review Board of 
Basel/Basel-Land, Switzerland. Inclusion criteria for non-pregnant controls 
were fair general condition, female sex, age ≥ 25 and ≤ 45 years and for blood 
donors fulfilling national criteria for blood donation. Exclusion criteria were 
current or previous systemic autoimmune disease, asthma, reconvalescence 
after major illness, surgery, current medication with corticosteroids, 
immunosuppressive agents and malignant neoplasia or chemotherapy within 
5 years before recruitment for the study.  
 Women with GDM were diagnosed according to the new 
recommendations of European Association for the Study of Diabetes and 
World Health Organization (WHO) for the 2-h 75-g OGTT as at least two 
	   79 
values greater than a fasting glucose of 5.1 mmol/l, a 1-h glucose of 10 
mmol/l, or a 2-h glucose of 8.5 mmol/l.  
 Human placentae were obtained from pregnant women who delivered 
healthy, singleton infants at term (> 37 weeks’ of gestation) undergoing 
elective Caesarean section. After written informed consent, 5 placentae 
samples for each group were collected and dissected from the middle cross-
section of villus tree within 15  min of the delivery. To compensate for intra-
placental variability, we collected 3 independent samples per placenta giving 
totals of 15 GDM and 15 control samples. Tissue was bluntly dissected to 
remove visible connective tissue, blotted dry on filter paper, snap frozen in 
liquid nitrogen and stored at -80 °C. Small pieces of tissues are embedded in 
optimal cutting temperature (OCT) compound (Tissue-Tek; Sakura Finetek 
USA) and kept at −80 °C until cryosection. 
 
Oral glucose tolerance test  
 Pregnant women at the 24th to 28th weeks of gestation, after 10 - 16 
hours of fasting give blood and the fasting glucose levels were tested. They 
drink the 300ml of Accu-Chek Dextrose O.G.-T. (Roche) that contains 75 
gram of glucose and give blood after 60 min and after 120 min, according to 
manufacturer’s instructions.  
 
Blood cell count and preparation of plasma and serum  
 Whole blood was collected into EDTA- and silicone-coated tubes 
(Sarstedt) and 25 µl of blood was analyzed by a Hemavet 950FS (Drew 
Scientific) for complete blood cell counts. Plasma and serum was collected 
and processed as described previously [190]. Samples were studied 
immediately or stored at -80°C until analyzed. 
 
Human neutrophil isolation  
 Neutrophils were isolated by Dextran-Ficoll density centrifugation [65]. 
Cell viability was assessed by trypan blue dye exclusion in a haemocytometer 
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and was routinely 96–98% with a purity of over 95%. Neutrophils were directly 
seeded in 24-well or 96-well plates and allowed to settle for 15 minutes at 
37°C under 5% CO2 prior to further experimentation. 
 
BeWo cells and co-culture conditions 
 BeWo cells (ATCC CCL-98) were grown at 37°C under a humidified 
5% CO2/95% air atmosphere in F-12K Medium containing 10% fetal bovine 
serum (FBS) and 1% penicillin/streptomycin. Experiments were performed in 
serum-starved conditions using cells at 80% confluence between passages 
30 and 40. BeWo cells were grown under low glucose (LG: 7 mM) or high 
glucose (HG: 25 mM) conditions. Supernatants were harvested, submitted to 
centrifugation, aliquoted, and frozen at −80°C until use. The co-culture 
experiments were performed in 6-well cell culture plates with 12 mm 
coverslips (Corning® BioCoat™ Coverslips). When indicated, neutrophils 
were directly added to the BeWo cells at a density of 0.5 × 106 neutrophil/ml 
for 3 hours. In neutralization studies, 5 ug/ml of chimeric anti-TNF IgG1 
antibody infliximab (Remicade, MSD) was given simultaneously to neutrophil 
addition.  Dr. Franco Grimolizzi performed all the experiments with BeWo 
cells.  
 
Fluorimetric quantification and fluorescence microscopy 
 NETs were quantified by SytoxGreen fluorimetry. 2.5 x 104 freshly 
isolated neutrophils were cultured in the presence of 0.2 µM SytoxGreen 
(Invitrogen, Life Technologies) in a 96-well dark microtiter plate at 37°C under 
5% CO2 and left untreated or stimulated with the aforementioned agents over 
3 hours. PMA was used as the positive control. Fluorescence (excitation 485 
nm, emission 535 nm) was measured in a Biotek Synergy H1 Hybrid Reader 
(Biotek) and results given as DNA fluorescence (MFI). Photomicrographs in 
bright field and green fluorescence spectra were assessed with an Olympus 
IX50 inverted fluorescence microscope coupled to an Olympus XM10 
monochromatic CCD camera and analyzed with the Olympus CellSens 
Dimension software (Olympus). 
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Immunohistochemistry and morphometric analysis 
 1x105 neutrophils were seeded on poly-L-lysine-coated glass 
coverslips (BD Biosciences) in 24-well tissue-culture plates and allowed to 
settle prior to stimulation as described above. Coverslips were rinsed with ice-
cold HBSS and the cells fixed with 4% paraformaldehyde and blocked 
overnight (HBSS with 10% FBS, 0.1% Tween20, and 2mM EDTA) at 4°C. 
NETs were detected with rabbit anti-NE (Abcam), rabbit anti-MPO (Dako) or 
mouse anti-MPO (Abcam) and rabbit anti-citrullinated histone H3 (citH3, 
Abcam). Secondary antibodies were goat anti-rabbit IgG AF555, goat anti- 
rabbit IgG AF488 (Invitrogen Life Technologies), and goat anti-mouse IgG 
AF647. DNA was stained with 4′,6-diamidino-2-phenylindole (DAPI, Sigma- 
Aldrich). NETs were visualized by using a Zeiss Axioplan 2 Imaging 
fluorescence microscope in conjunction with a Zeiss AxioCam MRm 
monochromatic CCD camera and analyzed with Axiovision 4.8.2 software 
(Carl Zeiss). A minimum of 20 fields (at least 1,000 neutrophils) per case were 
evaluated for MPO/NE and DNA co-staining; nuclear phenotypes and NETs 
were counted and expressed as percentage of the total number of cells in the 
fields. 
 In another set-up, NETs were quantified by IHC staining of 2.5 x 104 
neutrophils per well in a 96-well plate with rabbit anti-NE (Abcam), mouse 
anti-human MPO antibody (Abcam) and rabbit anti-human citH3 antibody 
(Abcam), or the respective isotype controls, followed by incubation with goat 
anti-mouse IgG AF555 and goat anti-rabbit IgG AF488 (Invitrogen Life 
Technologies). DNA was counterstained with 4′,6- diamidino-2-phenylindole 
(DAPI, Sigma-Aldrich). NETs were visualized by using an Olympus IX81 
motorized epifluorescence microscope (Olympus) in conjunction with an 
Olympus XM10 monochromatic CCD camera (Olympus) and analyzed with 
the Olympus CellSens Dimension software (Olympus). A minimum of 20 fields 
at 10X magnification (at least 500 to 1,000 neutrophils) per sample were 
evaluated for MPO/citH3 and DNA co-staining through ImageJ analysis 
software (NIH); nuclear phenotypes and NETs were determined, counted, and 
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expressed as percentage of the total area of cells in the fields [194]. Images 
were captured on a Nikon A1R inverted microscope (Nikon) coupled to a 
Visitron CSU-W1 spinning disc confocal microscopy module (Visitron) and a 
Thor ablation laser (Thor Labs) using an UPL APO 60x/1.40 oil objective lens 
with the Visiview Cell Analyser software (Visitron Systems, Version 3.1.2.2). 
 For double immunohistochemistry of the human placentas, 8 µm thick 
placental sections were fixed in 4% paraformaldehyde/PBS for 10 min, 
permeabilized by incubation with 0.2% Triton X-100 in PBS for 5 min and 
blocked in with 3% BSA/PBS for 60 min. Then, the slides were probed with 
first antibodies diluted 1:150 in PBS with 3% BSA and 0.05 % v/v Tween 20 
(staining buffer) for 1 hour at room temperature (RT). Primary antibodies used 
were: rabbit anti-citH3 (Abcam), rabbit anti-MPO (Abcam), NE (Hycult 
Biotech) and rabbit anti-IRS1 (Santa Cruz). Negative controls were obtained 
by incubating with isotype-specific mouse/rabbit IgGs (Santa Cruz) instead of 
the specific primary antibodies. Sections were then incubated for 1h at RT in a 
light-protected humidified chamber with Alexa 488-conjugated anti-rabbit (Life 
Technologies) and Alexa 647-conjugated anti-mouse (Life Technologies) 
secondary antibodies diluted 1:1000 in staining buffer. Sections were stained 
with DAPI (DAPI, Sigma-Aldrich), mounted in Mowiol (Sigma-Aldrich) and 
visualized using an Olympus BX61 Diana fluorescent microscope. In addition, 
a further consecutive section was stained using H&E for comparison against 
immunostained tissues. 
 
ROS generation analysis 
 BeWo cells were incubated overnight with different concentrations of 
NE (20-320 nM). The cells were washed twice with pre-warmed PBS, 
incubated with 10 µM 2′,7′-dichloro dihydrofluorescein diacetate (DCFH-DA) in 
PBS for 1 h at 37°C, and then resuspend in PBS. Fluorescence was 
measured with a multiplate reader (Synergy H4 Hybrid Multi-Mode Reader, 
BioTek, Germany) at 535 nm with excitation at 480 nm. 
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Cell-free nucleosome, NE and TNFα ELISA 
 Histone/DNA complexes in sera and plasma were measured using the 
Human Cell Death Detection ELISAPLUS (Roche Diagnostics). The 
concentrations of NE in sera and plasma were measured by sandwich ELISA, 
utilizing the Elastase/a1-PI Complex ELISA Kit (Calbiochem). TNFα 
concentrations in sera and plasma were assessed by sandwich ELISA with 
Human TNF-alpha DuoSet ELISA Kit (R&D Systems). 
 
Stimulation and neutralization studies 
 For in vitro incubation studies 2.5 x 104 neutrophils from healthy 
women were treated with 6% plasma derived from non-pregnant controls, 
pregnant donors and donors with GDM during second and third trimesters of 
gestation. All experiments were carried out over 3 hours in 4 to 6 replicates.  
 For similar in vitro incubation studies 2.5 x 104 neutrophils from healthy 
women were treated with supernatants from BeWo cells after exposure to 
normal or high glucose for 12h.  
 To neutralize TNFα, pooled plasma from the study groups of interest or 
BeWo supernatants were pretreated for 30 minutes with Infliximab (5ug/ml). 
 For the two-step stimulation in vitro experiments, neutrophils from 
healthy controls were pretreated or not with TNFα (50ng/ml) for 30min and 
then exposed to high glucose (25mM) for 150min, for a total time of 3 hours. 
 
Protein isolation and western blotting 
 Total cellular protein was extracted using Pierce RIPA Buffer (Thermo 
Scientific) supplemented with PhosSTOP Phosphatase Inhibitor Cocktail 
Tablets (Roche Life Science). For the placenta, frozen tissues were thawed 
for a few minutes in pre-chilled RIPA buffer and homogenized with a Polytron 
(Kinematica). Western blotting was performed by using AnykD Mini-
PROTEAN TGX Gels (Biorad, Hercules, CA, USA) and nylon/nitrocellulose 
membranes (Biorad). Primary and secondary antibodies used were: rabbit 
anti-IRS1 (Santa Cruz Biotechnology), rabbit anti-GLUT4 (Millipore) mouse 
anti-β-Actin (Sigma-Aldrich), goat anti-Mouse and/or anti-Rabbit, human anti-
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HRP (Santa Cruz Biotechnology). HRP activity was detected by using 
SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific). 
Densitometric analysis and protein quantification of the Western blots was 
performed by using Image Lab Software (version 5.2.1). Blots were stripped 
briefly in 0.2 M sodium hydroxide and reprobed for mouse anti-β-Actin 
(Sigma-Aldrich) as a loading control. 
 
RNA isolation and quantitative real-time PCR  
 Total RNA was isolated from 3x106 neutrophils by using the RNeasy 
Mini Kit (Qiagen). TaqMan real-time quantitative RT-PCR was performed 
utilizing the Applied Biosystems StepOne Plus cycler (Applied Biosystems) 
and TaqMan Gene Expression Assay primer and probe sets (Applied 
Biosystems) for ELANE (HS00236952_m1), TNF (HS01113624_g1) and 
RPLP0 (HS99999902_m1). Data were normalized to the housekeeping gene 
B2M (HS99999907_m1), after a selection procedure from six different 
endogenous reference genes, as suggested in the MIQE guidelines [195]. 
Relative values were calculated with 2-DDCt analysis [196]. 
 
Statistical analysis  
All data are presented as mean ± SE. Descriptive statistics for continuous 
parameters consisted of median and range, and categorical variables were 
expressed as percentages. Comparisons between patients and healthy 
controls were carried out by the Mann-Whitney U test with a Welch post- test 
correction. Statistical significance in multiple comparisons was by one-way 
analysis of variance (ANOVA) with a Dunn’s post-test correction. P values 
under < 0.05 were considered statistically significant. Data were processed in 
GraphPad Prism version 6.0 for MacOSX (GraphPad Software Inc., 
www.graphpad.com). Professional statistical assistance was provided by 
Andreas Schoetzau (www.eudox.ch).  
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Results 
GDM is characterized by primed circulating neutrophils which undergo 
excessive NET formation 
 We observed a marked increase in NET formation in vitro by 
neutrophils from GDM donors versus pregnant and non-pregnant controls, 
which at 3 hours was highly significant, as assessed by immunocytochemical 
fluorescent staining (Fig. 1a). This was reflected in augmented cell free 
nucleosomes in culture supernatants, which corresponds to the presence of 
NETs (Fig. 1b). The morphology of the neutrophil nucleus evolves from a 
lobulated to a primed phenotype, identified by citrullinated histone H3 staining, 
and then to excessive NETs formation, having a spread phenotype [37]. After 
assessing the fraction of primed neutrophils (citH3+) and those with the 
spread NETotic phenotype, it was evident that NET formation was elevated in 
patients with GDM (Fig. 1c, left panel), especially after incubation with PMA 
as an additional stimulus. High levels of primed citH3+ neutrophils were also 
observed (Fig. 1c, right panel). Although a substantial rise in neutrophil 
numbers was observed in pregnancies with GDM (Fig. 1d), this could, 
however, not solely account for the increase in neutrophil activation and NETs 
formation. Since serum and plasma cell free nucleosomes levels were also 
elevated in GDM (Fig. 1f), this is further suggestive of increased neutrophil 
NETotic activity in affected pregnancies. This activity was not restricted to 
NETs formation, as our analysis indicated that serum NE levels were also 
elevated when compared to healthy pregnant controls (Fig. 1e). Of interest is 
that NE levels were also greater in cases with GDM than those detected T1D 
and T2D patients (Fig. 1e), thereby clearly illustrating that GDM may have 
distinct clinical features different from other forms of diabetes. 
 To summarize, peripheral blood neutrophils exhibit a primed pro-
NETotic phenotype, which increases during the course of pregnancies with 
GDM, and are hyper-responsive to a secondary stimulus. This activation is 
associated with an increase release of NE. 
 
	   86 
 
Figure 1. NET formation and neutrophil pro-NETotic priming are augmented 
during GDM pregnancy. (a) In vitro spontaneous NET formation by neutrophils from 
non-pregnant controls, healthy pregnant donors and GDM patients in a 3 hour 
timecourse by Immunofluorescence staining for NE (green) and DNA counterstain 
with DAPI (blue) at baseline (0h), in 1 hour (1h) and after 3 hours of culture (3h). 
Magnification: 20x; Scale bars: 50 µm. (b) Quantification of cell free nucleosome 
levels in culture supernatants of neutrophils from healthy controls and pregnant 
donors at baseline (0h), after 1 hour (1h) and at 3 hours (3h) of culture. (c) 
Morphometric analysis of NETs (MPO+/DAPI+) and pro-NETotic primed neutrophils 
(citH3+) from healthy controls, donors during pregnancy, patients diagnosed with 
GDM, the latter treated with PMA as an secondary stimulus, all after a 3 hour culture 
(3h). (d) Neutrophil count in EDTA blood samples obtained from the enrolled healthy 
controls, pregnant donors and GDM patients. (e) Detection of serum NE levels by 
ELISA. (f) Detection of serum (left panel) and plasma (left panel) cell-free 
nucleosome levels by ELISA. Data are presented as mean ± SEM. *P < 0.05, **P < 
0.01, ***P < 0.001, ****P < 0.0001 (one way ANOVA followed by Bonferroni’s multiple 
comparison post-test). All experiments were performed at least 6 times with 
consistent results. GDM, gestational diabetes mellitus. 
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 High glucose primes human neutrophils towards NET formation in GDM 
 Since hyperglycaemia is frequently manifest in gestational diabetes 
mellitus, as indicated by the higher glucose levels compared to the healthy 
controls, we postulated that high glucose might contribute to neutrophil 
priming. Isolated neutrophils from healthy donors were cultured in media with 
normal (5.5 mM) or high (25 mM) glucose concentrations before stimulation 
with phorbol myristate acetate (PMA). SytoxGreen fluorimetry (Fig 2a, left 
panel and Fig. 2b) and immunofluorescence microscopy for NE, MPO and 
citH3 (Fig 2a, right panel, Fig. 2c and Fig. 2d) revealed that neutrophils 
exposed to high glucose became primed and generated more NETs 
compared to what we observed when incubated with normal glucose. Thus, 
the increased tendency of neutrophils from women with GDM towards NET 
formation is at least partially due to elevations in blood glucose. To further 
explore whether hyperglycaemia in patients with GDM predisposes 
neutrophils to increased NET formation, we isolated neutrophils from fresh 
whole blood obtained from individuals at the time of the diagnostic oral 
glucose tolerance test for GDM (OGTT) (Fig. 2f). Our analysis of circulatory 
neutrophils following exposure to high glucose during the OGTT test permitted 
a clear distinction between patients with GDM, normal pregnant controls and 
non-pregnant controls (Fig 2e, Fig. 2h, Fig. 2i), in that these cells were highly 
primed and pro-NETotic. This was confirmed by an examination of serum cell 
free nucleosomes (Fig. 2j) and NE mRNA expression levels (Fig. 2k), which 
were similarly elevated in cases with GDM, when compared to the 2 control 
groups. 
 Taken together, these data indicate that hyperglycaemic conditions in 
GDM have profound effects on neutrophil activity. 
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Figure 2. High glucose primes human neutrophils towards NET formation in 
GDM. (a) In vitro spontaneous extracellular DNA release monitored in a 3 hour time 
course by dsDNA-binding fluorescent SytoxGreen dye microscopy (left panel) and 
fluorescent immunocytochemistry for MPO, citH3 and DAPI counterstain (right panel) 
after treatment of control neutrophils with high concentrations of glucose. 
Magnification: 10x. Scale bars: 100 µm. (b) Three hour time course fluorimetric 
evaluation of SytoxGreen-bound extracellular DNA release from neutrophils treated 
high glucose concentrations. (c) NE protein expression morphometric evaluation of 
control neutrophils treated with high concentrations of glucose for 3 hours. (d) 
Morphometric analysis of the NETotic (MPO+/DAPI+, left panel) and pro-NETotic 
primed (citH3+, left panel) neutrophils from healthy control donors under high 
glucose treatment. (e) Evaluation of the effect of glucose during the diagnostic for 
GDM OGTT in neutrophils isolated from non-pregnant controls, healthy pregnant 
donors and GDM patients using fluorescent SytoxGreen staining DNA and 
microscopy (left panel) and immunofluorescence for MPO (red), citH3 (green) and 
DNA counterstain with DAPI (blue) after a 3 hour culture (right panel). Magnification: 
10x. Scale bars: 100 µm. (f) Glucose levels monitored during the OGTT utilized for 
the differential diagnosis of GDM. (g) Neutrophil count in EDTA blood samples 
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obtained from the enrolled healthy controls, pregnant donors and GDM patients 
during the diagnostic OGTT. (h) Fluorimetric analysis of peripheral neutrophils 
isolated from healthy controls, donors during healthy pregnancy and patients 
suffering from GDM enrolled for the diagnostic OGTT. (i) Morphometric analysis of 
the NETotic MPO positive (left panel) and pro-NETotic primed citH3 positive 
neutrophils (right panel) of neutrophils from the aforementioned diagnostic setup. (j) 
Detection of cell-free nucleosome levels by ELISA in sera from healthy controls, 
pregnant donors and GDM patients during the diagnostic OGTT. (k) Detection of NE 
levels in the aforementioned sera by ELISA. Data are presented as mean ± SEM. *P 
< 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (one or two way ANOVA followed by 
Bonferroni’s multiple comparison post-test). All experiments were performed at least 
6 times with consistent results. GDM, gestational diabetes mellitus; OGTT, oral 
glucose tolerance test; RFU, relative fluorescence units. 
 
TNFα is relevant for neutrophil activation and NET formation in GDM 
 Our data confirm previous reports that TNFα levels are elevated in 
cases with GDM (Fig. 3a). This is important in the context of our study as 
TNFα has been shown to promote neutrophil activation and pro-NETotic 
priming	   [226].	   Therefore, TNFα expression due to a hyperglycaemic 
microenvironment in GDM may facilitate enhanced NET formation or 
degranulation.  
 Our data support such a hypothesis since treatment of plasma from 
pregnant women with GDM with the TNFα receptor antagonist infliximab 
reduced the degree of NETosis when compared to untreated plasma samples 
applied on neutrophils (Fig. 3b and Fig. 3c). We further determined that the 
combination of high glucose and TNFα lead to high degrees of neutrophil 
priming, as detected by histone H3 citrullination and increased propensity for 
subsequent NETosis (Fig. 3d to 3f). 
Metabolic dysfunctions in GDM, such as hyperinsulinemia, hyperglycaemia, 
and dyslipidemia can induce functional abnormalities of the placenta and 
trophoblast cells in particular  [237]. It has been also suggested that TNFα is a 
predictor of insulin resistance in human pregnancy	   [226] and that 
neutralization of TNFα signaling leads to sufficient improvements in insulin 
sensitivity [238]. Since circulating neutrophils exert a pro-NETotic primed state 
in GDM, we hypothesized that TNFα production by trophoblast cells could 
lead to a neutrophil infiltration and activation. To explore this hypothesis, we 
employed BeWo choriocarcinoma cells, commonly used as a model system 
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for placental syncytiotrophoblast cells. Treatment of BeWo cultures with high 
concentrations of glucose in vitro, lead to increased TNFa production as 
assessed by both qRT-PCR of cell lysates and EIA of protein levels in the 
supernatants (Fig. 3h). When normal healthy control neutrophils were treated 
with these BeWo culture supernatants, they exhibited an increased NETotic 
potential, which was inhibited by addition of infliximab (Fig. 3h to 3j). In 
addition, when BeWo cells were co-cultured with control neutrophils under 
high glucose conditions, increased numbers of NETs were observed, which 
once again was reduced by inclusion of infliximab (Fig. 4a and Fig. 4b).  
 Collectively, these data show that TNFα, which is produced by BeWo 
cells after exposure to hyperglycaemic conditions in vitro, stimulates NET 
formation. It is hence plausible that such a mechanism may be operative in 
vivo in GDM. 
 
 
Figure 3. TNFα determines neutrophil activation and NET formation in GDM 
pregnancy. (a) Determination of TNFα levels in plasma samples from healthy non-
pregnant donors, women during their healthy pregnancies and pregnant women 
diagnosed with GDM. (b) NET formation assessed microscopically in a 3 hour time 
course with SytoxGreen DNA binding dye after in vitro incubation of control 
neutrophils with control plasma, pregnancy plasma and GDM plasma with and 
without pretreatment with the TNFα receptor antagonistic antibody infliximab. 
Magnification: 10x. Scale bars: 100 µm. (c) Fluorimetric evaluation of extracellular 
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DNA release in control neutrophils treated with the aforementioned series of plasma 
in the presence of anti-TNFR neutralizing antibody. (d) Fluorimetry of peripheral 
neutrophils isolated from healthy non-pregnant controls treated with high glucose 
concentrations, TNFα and both agents for a 3 hour time course, compared to 
treatment with PMA. (e,f) Fluorescent immunostainings for MPO (red), citH3 (green) 
and DNA (blue) (e) and morphometric analysis (f) of the NETotic MPO positive and 
pro-NETotic primed citH3 positive neutrophils from healthy non-pregnant donors 
under the aforementioned experimental setup. Magnification: 20x; Scale bars: 50 µm. 
(h) ELISA determination of TNFα levels in the supernatants from BeWo cells treated 
with high concentration of glucose. (i) Fluorimetric quantification of extracellular DNA 
release of control neutrophils cultured with supernatants from BeWo cells treated 
with high glucose concentration with and without the addition of infliximab. (j,k) 
Fluorescent immunostainings for MPO (red), citH3 (green) and DNA (blue) (j) and 
morphometric analysis (k) of the NETotic MPO+ and pro-NETotic primed citH3 
positive neutrophils from healthy non-pregnant donors under the aforementioned 
experimental setup. Magnification: 20x; Scale bars: 50 µm. Data are presented as 
mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 (one way ANOVA 
followed by Bonferroni’s multiple comparison post-test). All experiments were 
performed at least 6 times with consistent results. GDM, gestational diabetes 
mellitus; RFU, relative fluorescence units; PMA, phorbol myristate acetate; NG, 
normal glucose; HG, high glucose; sup., supernatant. 
 
 
Figure 4. TNFα originating from BeWo cells induces neutrophil activation 
which leads to excessive NET formation and NE release. (a) NET formation in a 
3 hour timecourse assessed microscopically by immunostaining for NE (red) and 
citH3 (green), counterstained with DAPI. Magnification: 20x; Scale bars: 50 µm. (b) 
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Morphometric analysis of the NETotic (MPO+) and proNETotic primed (citH3+) 
neutrophils from healthy control donors cultured under high concentrations of 
glucose, with or without pretreatment with the TNFα receptor antagonising antibody 
infliximab. Data are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, 
****P < 0.0001 (one or two way ANOVA followed by Bonferroni’s multiple comparison 
post-test). All experiments were performed at least 3 times with consistent results. 
The experiments were performed by Dr. Franco Grimolizzi. 
 
 
 Placental infiltration of primed neutrophils leads to excessive NE 
release and IRS1 degradation 
Since BeWo cells under hyperglycemic conditions express TNFα, which 
promotes neutrophil infiltration, activation and NETosis, we investigated 
whether these findings are valid in vivo in placentae from pregnant women 
diagnosed with GDM. Indeed, an intense inflammatory cell infiltration was 
observed in GDM placentas, as evaluated by H&E stainings (Fig. 5a), which 
was predominantly of neutrophilic content, as confirmed by MPO 
immunostaining (Fig. 5b). Strikingly, numerous of these cells are in a primed 
citH3+ state, while a proportion of these infiltrating neutrophils appear to be 
undergoing NETosis (Fig. 5c). Neutrophil activity is, however, not restricted to 
NETosis, since placental lysates from GDM patients contained increased 
levels of NE mRNA and protein levels when compared to normal pregnancies 
(Fig. 5d). 
 Recent reports have described a significant neutrophil infiltration of 
adipose tissue of diabetic patients, accompanied by elevated release of 
neutrophil elastase (NE) and activity	  [233]. It was also observed that inhibition 
of NE led to a remarkable improvement of glucose tolerance and insulin 
sensitivity in vivo. The mechanism leading to altered glucose metabolism was 
shown to involve the degradation of insulin receptor substrate 1 (IRS1) in 
hepatocytes by exogenous NE, thereby inhibiting insulin-driven signal 
transduction, akin to a mechanism previously described in lung cancer cells	  
[239].  
 In order to investigate if such a mechanism is operative in the case of 
GDM, placental sections were examined by fluorescent 
immunohistochemistry for NE and IRS1. This revealed more pronounced NE 
positive areas in cases with GDM when compared to controls (Fig. 5d). 
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Interestingly, staining for IRS1 was reduced in GDM placentae compared to 
healthy pregnancy controls (Fig. 5e). This reduction in IRS1 protein levels was 
confirmed by immunoblot analysis of placental lysates from the same GDM 
patients. 
 Treatment of BeWo cells with recombinant NE lead to a 10 fold 
reduction of IRS1 protein levels and a 2 fold reduction in the glucose 
transporter type 4 (GLUT4) protein levels (Fig. 5g). These changes indeed 
affected glucose metabolism by BeWo cells, as assessed by the uptake of 
tritiated glucose, which indicated this was significantly reduced in BeWo cells 
subjected to exogenous recombinant NE (Fig. 5h). This effect was largely 
neutralized by addition of insulin (Fig. 5g and Fig. 5h).  
 These data underline the NE, and possibly NETs, in dysregulating 
trophoblast glucose uptake and tolerance. 
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Figure 5. Primed neutrophils infiltrate in the GDM placenta leading to excessive 
NE release and IRS1 degradation. (a) H&E staining of tissue sections from term 
placentas of normal pregnancy and a patient diagnosed with GDM. Magnification: 
20x; Scale bars: 50 µm. (b,c) Fluorescent immunostaining for MPO (red), citH3 
(green) and DNA counterstain (blue) (b) and morphometric analysis of the NETotic 
MPO positive and pro-NETotic primed citH3 positive neutrophils (c) in tissue sections 
from term placentas of normal pregnancy and a patient diagnosed with GDM. 
Magnification: 20x; Scale bars: 50 µm. (d) NE protein (left panel) and mRNA 
expression levels (right panel) determined by morphometric analysis and qPCR, 
respectively in placental tissue lysates from healthy placentas and GDM patients. (e) 
Fluorescent immunostaining and confocal microscopy of tissue sections from term 
placentas of normal pregnancy and a patient diagnosed with GDM. Magnification: 
20x; Scale bars: 50 µm. (f) Western blot analysis (upper panel) and densitometry for 
IRS1 protein expression (lower panel) in placental tissue lysates from healthy 
placentas and GDM patients. (g) Immunoblot analysis for IRS1 and GLUT4 protein 
expression in BeWo trophoblast cell lysates after treatment with NE, with insulin and 
both agents (left panel) and densitomentry for IRS1 (middle panel) and GLUT 4 
protein expression (right panel). Data are presented as mean ± SEM. *P < 0.05, **P 
< 0.01, ***P < 0.001, ****P < 0.0001 (one way ANOVA followed by Bonferroni’s 
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multiple comparison post-test). All experiments were performed at least 3 times with 
consistent results. GDM, gestational diabetes mellitus; AU, arbitrary units. 
Dr. Franco Grimolizzi performed these experiments.  
 
 
Discussion 
 In GDM the metabolic and circulatory adaptations to pregnancy are 
impaired, leading to hypertension, poor placental blood perfusion and failure 
to respond properly to crucially relevant hormones such as insulin. The fetal, 
neonatal and maternal adverse outcomes associated with GDM result from 
the altered metabolic milieu, which are projected on the fetus via the placental 
interface. These effects have immediate consequences for the health of both 
the mother and baby, but may also affect their future health.  
 Here we show that GDM is characterized by peripheral blood 
neutrophils spontaneously undergoing NETosis. This process is directly 
related to the high glucose levels present in the blood of the mother, which 
primes neutrophils towards NET formation.  
 The inflammatory milieu resulting from high glucose levels, similar to 
T1D and T2D, additionally stimulate the production and release of TNFα, that 
in turn increases spontaneous NETosis of circulating neutrophils thus 
regulating the release of NE. In the placenta, infiltration of primed overreactive 
neutrophils leads to forced NE release, which induces the degradation of 
IRS1, possibly resulting into organ specific metabolic changes, contributing to 
the placental pathology of GDM. 
 Several studies during the last years attempted unsuccessfully to 
correlate the incidence of GDM to the ratio of neutrophils to lymphocytes and 
other blood cells. Herein we observe a marked increase of the neutrophil total 
number in GDM pregnancy compared to healthy gestation that is already 
higher than in non-pregnant healthy women. Neutrophils from pregnant 
women with GDM massively increased their tendency for spontaneous 
release of NETs, when compared to healthy pregnancy. In serum and plasma 
the amount of free nucleosomes is extremely high, which cannot be justified 
solely by the increased number of circulatory neutrophils. Since freshly 
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isolated neutrophils from patients diagnosed with GDM showed increased 
expression of MPO and citH3, overt NETosis results from this enhanced 
primed phenotype.  
 It was previously shown that hyperglycaemia increases NETs formation 
in vitro by priming neutrophils and constitutively activates NETosis, leading to 
reduced responses to subsequent external stimuli [234]. In our case, addition 
of a secondary stimulus like PMA exacerbated NET formation. Kummer et al., 
recently described utilizing an in vitro model that elevated glucose 
concentrations in the range of glucose levels found in the peripheral blood of 
uncontrolled diabetics, were able to activate neutrophils altering their 
metabolic oscillation response	   [240]. To mimic the initial exposure of 
neutrophils to high glucose levels like in the insurgence of GDM we directly 
stimulated neutrophils from healthy non-pregnant donors with glucose and we 
confirmed the stimulatory properties of glucose directing NETs formation. 
Since neutrophils during pregnancy exhibit already a primed NETotic status, 
we took advantage of the diagnostic oral tolerance test for GDM to study the 
direct exposure of neutrophils to high glucose in vivo. For diagnostic 
purposes, pregnant women ingest 75 g (Check) glucose after 8 to 12 hours of 
fasting and their ability to assimilate blood glucose levels during a 2 hours 
period is measured. Also in this case we observed neutrophils primed towards 
formation of NETs, presenting elevated citrullination of histone 3 and MPO 
levels. Interestingly, priming of neutrophils is not correlated with a parallel 
increase neutrophil numbers in this short time, excluding a possible direct 
effect of high levels of glucose on the mobilization of neutrophils from the 
bone marrow during pregnancy. We concluded that glucose is a direct 
activator of neutrophils towards NETosis. This hypothesis was also confirmed 
by Rodriquez-Espinosa et al., which studied the metabolic requirement to 
produce NET. They were able to show that NETs formation is dependent on 
external glucose and to a lesser extent on glutamine	  [241].  
 The next issue arising concerning the role of glucose on proNETotic 
priming neutrophils and active NET formation implies an additional cytokine 
mediated effect. Since it was shown that TNFα levels in GDM are elevated 
compared to normal pregnancy	  [242] we studied the role of TNFα in presence 
of high glucose and the TNFα inhibitor Infliximab. First, we confirmed the 
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elevated level of TNFα in the plasma of pregnant women with GDM. Moreover 
when we blocked TNFα in GDM derived plasma, NET formation was also 
inhibited, although glucose levels in the plasma were still high. This suggests 
that glucose induces TNFα and together they synergize towards neutrophils 
proNETotic priming leading to excessive NET formation. Interestingly we 
could measure increased TNFα release upon stimulation of BeWo cells with 
high glucose concentrations, BeWo being an endocrine active cell line of 
trophoblastic origin used as an in vitro model for placental function. Co-culture 
of BeWo with control untreated neutrophils from non-pregnant female donors 
resulted in increased priming and NET formation. This effect could be 
reversed by addition of infliximab, stating the importance of TNFα in this 
process.  
 Increased NET release correlated with the augmented local exposure 
of the underlining tissue to neutrophil-derived serine proteases, such as NE. 
In addition to host defence, NE has also been implicated in sterile 
inflammation	   [2], while NE directly induces tumor cell proliferation in both 
human and mouse lung adenocarcinomas by directly degrading insulin 
receptor substrate-1 (IRS-1)	   [239]. Furthermore, treatment of hepatocytes or 
adipocytes with NE resulted in insulin resistance, and, in the context of 
diabetes, NE knock out mice were protected from inflammation of liver and 
adipose tissue	   [233]. Indeed, we first observed excessive inflammatory cell 
infiltration directly in biopsies from GDM placentae. This infiltration was 
primarily comprised by primed PMN. Strikingly, we also observed excessive 
local abundance of NETs, which is accompanied by extensive release of NE. 
Moreover, immunohistological staining and immunoblot revealed a 
simultaneous decrease of IRS-1 expression in placentae from GDM patients. 
To confirm the mechanistic aspects of this observation, BeWo cells were 
treated with recombinant elastase and insulin. Elastase treatment leads to 
downregulation of IRS-1 expression in vitro. Glucose intolerance was also 
evident, as shown by the downregulation of GLUT4 glucose receptor 
expression and the capacity of glucose uptake in BeWo cells, while insulin 
could partially reverse these effects. These data suggest a possible role of NE 
and IRS1 to the aetiology of inflammation-induced insulin resistance and the 
altered placental physiology during GDM. 
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 Collectively, we propose that neutrophils participate directly to the 
pathobiology of GDM. Our data show that the TNFα driven inflammation, 
resulting from high glucose levels in the circulation, augments neutrophil 
priming and NET formation. The released NE can locally modify glucose 
tolerance and metabolism in the placenta, which probably results to the 
anatomical, physiological and functional changes observed in placenta of 
pregnant women suffering from GDM (Fig. 6). Our findings underline the 
competence of NETs as a highly relevant diagnostic biomarker for GDM, and 
NE and TNFα as potential prophylactic and therapeutic targets in GDM.  
 
 
Figure 6. Neutrophils are involved in the pathogenesis of gestational diabetes 
mellitus via TNFα mediated NE release and excessive IRS1 degradation. 
Circulatory neutrophils during GDM pregnancy lie under the increased influence of 
glucose. This appears to poise the neutrophils in a stable pro-NETotic primed state. 
Depending on the stimulus, for instance TNFα, primed neutrophils transmigrate to 
the placenta and react with overt degranulation and extrusion of NETs. This 
excessive NE release modulates the tolerance of the placental trophoblast to glucose 
via controlling the IRS1-dependent glucose uptake. Dysregulation of these pathways 
may cause serious pathogenetic consequences as the ones appreciated in the GDM 
placenta. 
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